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Abstract
Chronic venous insufficiency is a chronic disorder where venous pressure is not
reduced during exercise. In a healthy individual, the vein valves and muscle pumps of
the extremities combine to allow for a reduction in venous pressure during exercise.
Consistent high pressure in the leg can lead to disability, pain, and ulcer formation.
Typical causes of chronic venous insufficiency are venous reflux and acute venous
obstruction. Research is under way to develop a prosthetic vein valve that can easily
be implanted with a minimally invasive catheter procedure which addresses chronic
venous insufficiency. This thesis discusses development of an in vitro test system in
order to evaluate new prosthetic venous valves.
A lumped parameter model of the leg venous system is developed which can
simulate venous pressure and flow during calf muscle action while standing. A table
top representation of the lumped parameter model is constructed, and the system is
tuned to have a physiological ankle pressure response during exercise. The effects of
an ideal venous valve, a missing or incompetent venous valve, and an acute thrombosis
are all used as baseline conditions to ensure a physiological response. During tuning,
system parameters are adjusted in order to match physiological ambulatory venous
pressures and pressure recovery times.
After the system has been tuned to have an accurate pressure response for
all baseline test sections, ambulatory venous pressure and flow rate through each
ii
test section lie within a physiological range. This is the first time physiological
pressure response during exercise has been modeled for patients with chronic venous
insufficiency, both due to high reflux and acute thrombosis. Evaluation of a biological
test section yields an ambulatory venous pressure in the range sufficient to reduce
risk of venous ulceration, yet has a high reflux flow rate. suggests that reflux flow
rate may be an inappropriate parameter for in vitro evaluation of prosthetic valves
when not paired with simulation of physiological pressure response.
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Chapter 1
Introduction
1.1 Motivation and Background
Chronic venous insufficiency (CVI) is a venous disorder resulting from ambula-
tory venous hypertension, which is failure for venous pressure to reduce with exercise
[1]. Causes of chronic venous insufficiency include venous reflux, venous obstruction,
and impaired calf muscle function [1,2]. For many patients, conservative treatment
options are sufficient. However, the most common conservative treatment, compres-
sion sleeves can be dangerous to the patient if not used correctly, and surgical and
pharmaceutical solutions are either much more invasive, ineffective, or not approved
for use in the United States of America [2--4]. In order to address the shortcomings
of current treatments for chronic venous insufficiency, much research has been done
to develop a prosthetic vein valve which can be implanted in a minimally invasive
manner by utilizing a catheter [5--7]. The goal of this research is to develop an in
vitro test system for evaluation of prosthetic vein valves, to aid in development of a
minimally invasive treatment for chronic venous insufficiency.
1
1.1.1 Healthy Venous Circulation
To appreciate the physiology of CVI normal venous anatomy and function must
be understood. The peripheral venous system functions both as a conduit by which
blood is returned to the heart, and as a reservoir for blood storage. It depends on a
series of valved conduits and muscle pumps to return blood to the central circulation
[1,4] . Blood that enters the venous system of the lower extremities must fight gravity
and fluctuating thoracoabdominal pressures to return to the central circulation when
the person is in an upright position. A series of bicuspid valves are located throughout
the deep and superficial veins in order to ensure that blood moves in the proximal
direction and to prevent the return of blood to the feet when in the upright position
[4]. Figure 1.1 displays the fluid dynamics of a vein valve, and the distinct phases of
opening and closing of the valve leaflets [8]. Perforating veins also contain valves to
prevent regurgitant flow from the deep venous system to the superficial veins [4].
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Figure 1.1: Fluid dynamics of a valve: From Bazigou and Makinen [8]
The valves function together with venous muscle pumps to allow the return of
blood to the central circulatory system. The primary muscle pump is the contraction
of the calf muscle, but the foot and thigh muscles also play roles in venous circulation
[4]. When the calf muscle contracts, the deep veins are compressed, pressure rises,
and blood is propelled proximally [2]. This process is illustrated in Figure 1.2.
3
Figure 1.2: Illustrations of the venous muscle pumps: From Stranden [9]
The venous system of the lower extremities is composed of three main com-
ponents. The deep veins lie beneath the muscle tissue and drain the muscles; the
superficial veins lie above the muscle tissue and drain microcirculation of the skin;
and perforating veins which penetrate the muscular tissue and connect the deep and
superficial veins. These vein classifications can be seen in Figure 1.3 [1]. The deep
venous system in the leg is the focus of this experiment, and is shown in Figure 1.4
[1].
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Figure 1.3: Vein classifications of the lower extremities showing a. superficial veins,
b. perforating veins, and deep veins: From Meissner et al. [1]
Figure 1.4: Deep veins of the leg: From Meissner et al. [1]
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1.1.2 Chronic Venous Insufficiency
The most frequent causes of CVI are abnormalities of the venous wall and
valve that can lead to reflux, venous obstructions, or both [3]. Figure 1.5 displays
these mechanisms underlying chronic venous insufficiency. CVI is estimated to affect
2.5 million people in the United States of America [4]. If left untreated chronic venous
insufficiency can lead to the formation of ulcers in the extremities [1]. Disability due
to venous ulcers leads to an estimated 2 million workdays/year lost in the United
States, and often causes early retirements [4]. The estimated total cost of chronic
venous insufficiency in the United States is greater than $1 billion, and is estimated
at $1 billion in Germany, France, and the United Kingdom each [3, 4]. Figure 1.6
shows several manifestations of chronic venous insufficiency.
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Figure 1.5: Underlying mechanisms of chronic venous insufficiency: A. incompetent
or missing valves in superficial, perforating or deep venous systems, B. deep venous
obstruction C. muscle dysfunction: From Valencia et al. [2]
7
Figure 1.6: Manifestations of chronic venous insufficiency: A. varicose veins, B.
hyperpigmentation, dermatitis, and severe edema, and C. active and healed venous
ulcers: From Eberhardt and Raffetto [4]
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1.1.3 Therapies for Chronic Venous Insufficiency
1.1.3.1 Compression
Compression therapy is typically the first therapy considered for patients
diagnosed with chronic venous insufficiency [4]. Compression sleeves of varying
external pressure levels are placed around the affected region in order to reduce edema
and help heal venous ulcerations [2, 3]. A combination of rigid and elastic bandages
can be used, with rigid bandages used to provide support, and elastic bandages used
to apply pressure to the desired area during muscle action [2].
1.1.3.2 Medication
There are several groups of drugs which can be used to treat CVI, but none
have been approved for use in the United States. These drugs act primarily through
improving venous tone and capillary permeability [4]. Other prescriptions and over
the counter drugs can improve the healing of venous ulcers and reduce the symptoms
of chronic venous insufficiency [2].
1.1.3.3 Exercise
In some cases of chronic venous insufficiency, abnormalities in the calf and
foot muscle pump have a large impact on the pathophysiology of the condition. In
order to reduce the effects of the disease, calf muscle exercise routines can be used to
reduce symptoms when paired with other treatment options [4].
1.1.3.4 Sclerotherapy
Sclerotherapy is a method of vein obliteration where a solution is directly
injected into superficial veins. This causes the vein to scar and collapse. It can be
9
used to treat a number of superficial conditions. In patients who have superficial
chronic venous insufficiency, sclerotherapy can be the primary treatment option, or it
can be used in combination with other treatments [4].
1.1.3.5 Venous Ligation and Phlebectomy
Venous ligation and phlebectomy are methods used redirect flow in the leg.
Ligation is when the vein is closed, and phlebectomy is when the vein itself is removed
[4]. These methods can be effective at reducing the recurrence of venous ulcers when
the deep veins are competent, but if the deep veins are prone to reflux, ligation and
phlebectomy may be ineffective [2].
1.1.3.6 Valve Reconstruction
Valve reconstruction is an extremely challenging new field of CVI treatment,
but has a record of improved functional outcome [3]. A technique for repairing the
femoral vein valve has been shown to render valve leaflets competent, however this
requires an invasive open surgery [4].
1.2 Review of Previous Work
Eberhardt and Raffetto discuss the pathology, diagnosis, and treatment options
of chronic venous insufficiency. Figure 1.7 displays an illustrative pressure curve
for healthy venous flow. The resting standing pressure should be between 80 and
90 mmHg. The pressure drops with calf exercise > 50% to between 20 and 30 mmHg.
The pressure recovery time is > 20 s. Figure 1.8 is an illustrative pressure curve for
venous flow in a patient with deep chronic venous insufficiency. The resting standing
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pressure is the same as in a healthy patient, between 80 and 90 mmHg. The pressure
drop with calf exercise is < 50%. The pressure recovery time is rapid, < 20 s [4].
Figure 1.7: Normal venous pressure: From Eberhardt and Raffetto [4]
Meissner et al. clearly show that the pressure measured uses a datum pressure
at the level of the heart. They have a clinical pressure tracing of the pressure change
induced by performing 10 tip-toe maneuvers. Then allowing pressure to return to rest
as shown in Figure 1.10. The article also contains an illustrative graph of volume
and pressure change of continuing tip-toe maneuvers as shown in Figure 1.9. They
show how the minimum pressure is reached after approximately 10 tip-toe maneuvers.
This minimum is a value known as ambulatory venous pressure (AVP). Meissner et
al. discuss how an AVP over 30mmHg is linked to high rates of ulceration [1].
Hosoi et al. recorded venous pressure during tip-toe maneuvers and recovery
[10]. The steady state pressure range found by Hosoi et al.l agrees with the values
found by Eberhardt and Raffetto [4,10]. Lee et al. describe an in vitro test system
11
Figure 1.8: Abnormal venous pressure with deep venous reflux: From Eberhardt and
Raffetto [4]
Figure 1.9: Volume and Pressure vs Time: From Meissner et al. [1]
for evaluating venous valves. They focus on flow rates, and give a maximum flow
rate between 10--13mL
s
[11]. Moriyama et al. evaluate valves created using by
electrospinning, they evaluate valve parameters and set up a mock circulatory system
which shows system pressure in response to the muscle pump as shown in Figure 1.11.
This group addresses the main clinical parameter of interest, pressure drop, but their
model is insufficient. As can be seen in Figure 1.11, for the open prosthetic vein
valve and the no device test case, the pressure drops to steady state and recovers
12
Figure 1.10: Clinical pressure tracing: From Meissner et al. [1]
instantaneously [6]. This is not a physiologically relevant result, and does not mimic
pressure tracings of patients with CVI as shown in Figure 1.8 [4, 6].
Recek describes pressure gradients in the legs, and how these affect flow. The
article contains illustrative pressure curves which demonstrate both healthy flow and
flow in a patient with chronic venous insufficiency, as shown in Figure 1.12 [12].
Pollack and Wood found pressure in the ankle in subjects during exercise and changes
in posture. Figure 1.13 shows an average of pressure drop during calf pump function
[13]. Negle´n and Raju, and Comerota describe that venous outflow obstruction caused
by acute deep venous thrombosis can lead to an increase in venous pressure of the
lower limb during exercise [14,15]. Stranden has an illustrative superficial pressure
graph which, in part, shows the pressure rise due to deep venous obstruction. This
graph is shown in Figure 1.14. Stranden also describes how during calf muscle action
pressure in the vein can increase by over 200 mmHg [9].
Mackman describes risk factors that may lead to venous thrombosis [16]. Moore
et al. describe the location and number of vein valves in the femoral and popliteal
vein valves, and found that venous valves tend to be located in specific sites in the
studied veins [17].
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Figure 1.11: Mock circuit pressure response for a. biomimetic prosthetic venous valve
(bPVV), b. open prosthetic venous valve (oPVV), and c. no device: From Moriyama
et al. [6]
Tien et al. and Lurie and Kistner discuss how pairing two valves with different
orientations can create complex flow patterns and increase efficiency of the valve unit
[18, 19]. Bazigou and Makinen describe the functionality of vascular valves. They
describe fluid dynamics and geometry of functional vein valves [8].
DeLaria et al. evaluate bovine jugular vein conduits which contain one bileaflet
venous valve. Valve opening time, valve closing time, and valve competence were
measured under pressure change [20]. Zervides and Constantinos give a background
on previous studies on bioprosthetic vein valves [21]. Sathe and Ku test valves and de
Borst and Moll determine opening pressure, reflux flow rate, cyclic life functionality,
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Figure 1.12: Schematic illustration of the damped venous pressure in the incompetent
greater saphenous vein in the lower leg during the calf pump muscle: From Recek [12]
Figure 1.13: Average changes in venous pressure at the ankle produced by walking
1.7 miles per hour (10 subjects): From Pollack and Wood [13]
and burst pressure testing [5, 7]. Pavcnik et al. and describe previous bioprosthetic
vein valve construction techniques, delivery systems, and test results [22--24]. Rittgers
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Figure 1.14: Superficial venous pressure during walking: From Stranden [9]
et al. test bioprosthetic vein valves while standing and lying down, and while the calf
muscle is active while flow is driven by respiration [25].
Snyder and Rideout developed an analog network computer model for the
whole circulation [26]. Pittaccio et al. developed a lumped parameter model simulation
of the analog computer model described by Snyder and Rideout, and developed new
scaling rules for the lumped parameters based on patient size [27]. Zervides et al.
have developed a computation model of hemodynamics in the lower limb. They utilize
a one-dimensional mathematical model of a collapsible tube, with valves in varying
positions, and a varying gravity field [28]. Fragomeni et al. developed a venous
network model containing both the deep and superficial venous branches [29,30].
16
Chapter 2
Methods
2.1 Lumped Parameter Model
The mock circulatory system is based on a lumped parameter model (LPM)
of the human circulatory system. An analog (LPM) model of the venous system is
described by Snyder and Rideout [26], and is shown in Figure 2.1. For practical lab
implementation, the network is reduced to fewer elements. Reducing a model allows
for the complex impedance of the original system to be preserved for the predominant
range of frequencies while reducing the number of degrees of freedom in the system,
an example of this is found in Vukicevic et al. [31].
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Figure 2.1: Lumped parameter model of venous circulation: From Snyder and Rideout
[26]
The model is trimmed at the vena cava (PAV C), the calf muscle (Pm), and the
capillaries (FLCAP ) as shown in Figure 2.2. Appropriate boundary conditions are then
chosen for the capillaries and the vena cava. The boundary condition for the vena
cava when a person is standing is a constant pressure shown as Pivc in Figure 2.3, and
the boundary condition of the capillaries is one directional flow through the capillary
inflow branch as shown in Figure 2.3. Pivc is represented in the mock circuit by a
constant pressure head tank. The capillary inflow branch is represented in the mock
circuit a gate valve and resistance element connected to the constant pressure head
tank. R17, R18, and the valves in Figure 2.2 are represented as the test section in
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Figure 2.3, and are represented in the mock circuit as the various test sections outlined
in Section 2.5. R19, R20, the valves, and C6 in Figure 2.2 are represented as Csveg, Rsve,
and Csve in Figure 2.3. Csveg is represented by an open tank compliance as outlined in
Section 2.3.3. Csve is represented by an air chamber compliance element as outlined in
Section 2.3.1, and Rsve is represented with a valve resistance test section as outlined in
Section 2.2.1. C5 in Figure 2.2 is represented as Cmp in Figure 2.3. Cmp is represented
in the mock circulatory system using a flexible membrane compliance element as
outlined in Section 2.3.2. Pm in Figure 2.2 is represented as Pmp in Figure 2.3. Pmp is
represented in the mock circulatory system by applying a high to low air pressure to a
flexible membrane compliance element as outlined in Section 2.4. R15, R16, CFEV and
the valves in Figure 2.2 are represented as Rfem, Cfem, and Rivc in Figure 2.3. Cfem
is a nonlinear compliance element, but as mentioned in Snyder and Rideout, using a
linear relation should introduce at most a pressure error on the order of 0.5 mmHg [26].
Cfem is represented by an air chamber compliance element as outlined in Section 2.3.1.
Rfem is represented with a valve resistance test section as outlined in Section 2.2.1.
Rivc is the resistance of the tube connecting the constant pressure head tank to the
Cfem. The resistance of this section is found as outlined in Section 2.2.2.
19
Figure 2.2: Trimmed model of venous circulation
Each element in the LPM can be represented by a physical, analog element.
Fluid systems are analogous to electrical systems, with compliance analogous to
capacitance, inertance analogous to inductance, and fluid resistance is analogous to
electrical resistance. This fact allows for circuit laws to be used to predict pressures
and flows throughout the circuit. By only selecting part of the model, selecting
appropriate boundary conditions, and linearizing the nonlinear elements a reduced
lumped parameter model can be found and is shown in Figure 2.2.
20
Figure 2.3: Lumped parameter model of venous circulation in leg
Full Name Acronym
Small Veins Gravity sveg
Small Veins sve
Venules vn
Femoral fem
Inferior Vena Cava ivc
Muscle Pump mp
Table 2.1: Circuit labels
2.2 Resistance Elements
In the mock circulatory system, there are several different kinds of resistance
elements used to represent resistances from the lumped parameter model. The two
primary resistance elements used in the mock venous circulatory systems are valves
and tube resistors. The general equation for resistance is shown in Equation 2.1.
R =
(∆P )n
Q
(2.1)
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where R is resistance, ∆P is the pressure drop across the resistor, and Q is the flow
rate through the resistor, and n is a process factor. n = 1 if the flow through the
resistor is laminar, and n = 1
2
if the flow is fully turbulent. At the low flow rates found
in the mock circulatory system, the Reynolds number is low enough that laminar flow
can be assumed [32].
In order to determine a resistance value, pressure transducers are placed across
the resistance element and a flow probe is placed in-line. This includes any tubing
along the flow path as it adds to resistance. When pressure drop and flow rate are
being measured, Equation 2.1 can be used to find the resistance of the circuit section.
2.2.1 Valve
Valves are a way to create a large resistance in a fluid system. Any valve will
work to create resistance in the system, but a ball valve, as shown in Figure 2.4 is
used as it has minimal resistance, is easily adjustable, and when fully open and it
creates the least disturbance to flow.
The valve can be adjusted to change resistance until the desired value is
achieved. A drawback of the valve resistor is that the pressure-flow rate curve is
non-linear and this non-linearity is accentuated in turbulent flow, This can be a
problem if the flow rate varies substantially with time, as it leads to a non-constant
resistance value. For the flow rates found in this circuit, the flow remains laminar
throughout, however, nonlinearity remains a concern that needs to be monitored in
pulsatile flow, regardless of flow character.
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Figure 2.4: Ball Valve
2.2.2 Tube Resistance
Resistance is also caused by all tube lengths in the system. For laminar flow,
the resistance of a horizontal pipe is given by Equation 2.2.
R =
128µL
piρD4
(2.2)
where L is the length of the tube, D is the diameter of the tube, µ is the fluid viscosity,
and ρ is the fluid density [33]. Resistance due to tube length are in series with
bulk resistances, and must be included when finding the total resistance of a circuit
segment.
2.3 Compliance Elements
Compliance elements mimic the natural expansion and contraction of blood
vessels and organs under the action of pulsatile pressure, respiration, and muscle
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action [32]. In the mock circulatory system, several different compliance elements are
used to represent the lumped compliance values from the lumped parameter model.
The general equation for compliance is shown in Equation 2.3.
C =
∆V
∆P
(2.3)
where C is compliance, ∆V is change in volume, and ∆P is change in pressure [32].
In the circuit shown in Figure 2.3, compliance is simulated by three different physical
methods: air chamber compliance elements, flexible membrane compliance elements,
and tank compliance elements.
2.3.1 Air Chamber Compliance Elements
Air chambers are compliance elements that are inserted directly in the flow
lines. Each chamber contains a prescribed amount of trapped air volume suitable to
simulate the compliance desired. When the system liquid is under pressure, some
water enters the chamber causing a small compression in the trapped air. If the water
in the circuit experiences a decrease in pressure, then the air will decompress and the
stored energy will be released into the system. The air acts as a pneumatic spring,
storing energy when compressed and releasing energy when relaxed; in essence it is an
analog of a physical capacitor.
The formula for calculating air chamber compliance is shown below in Equa-
tion 2.4.
C =
∀
nP
(2.4)
where ∀ is the volume of trapped air, n is a process factor, and P is the absolute
pressure [32]. For this experiment, the process factor is equal to 1 which means
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(a) Large air chamber (b) Small air chamber
Figure 2.5: Sizes of air chambers
that the action of the air chamber is an isothermal process. The determination of
this process factor is shown in Appendix A. In order to set the compliance of an air
chamber, the pressure experienced by the air chamber at steady state is found. For
the mock circulatory system, there will be no steady state flow, so the pressure will
be hydrostatic pressure. In this case, the steady state pressure will be Pivc. This
absolute pressure and the volume of trapped air is used in Equation 2.4 to calculate
the compliance of the air chamber element. In order to tune a large air chamber with
an adjustable air cap like the one shown in Figure 2.5a, the mock circulatory system
is placed at steady state, and then the cap of the air chamber is moved until the
right volume of air is trapped in the air chamber. For small air chambers like the one
shown in 2.5b, with only a Schrader valve, the system is placed in steady flow and
the Schrader valve is opened to allow water to enter the chamber. When the water
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has risen to the proper level, the valve is closed. This allows for the compliance of the
element to be reliably changed during tuning [32].
2.3.2 Flexible Membrane Compliance Elements
The muscle pump compliance of the mock circulatory system is represented
by using a rubber tube (bicycle inner tube) inside of a plastic air tight chamber.
This technique allows for applying a time-dependent pressure onto the element so
as to simulate a muscle pump signal. System fluid flows through the hose which is
attached to pipes which flow through the chamber walls. The air-side of the chamber
has connections which allow a time-dependent pressure signal to be applied to the
chamber. Air is controlled as outlined in Section 2.4.
Figure 2.6: Flexible membrane compliance chamber
In order to calculate the compliance of the flexible membrane compliance
elements, one outlet of the chamber is capped to prevent flow, and the other outlet is
attached to a vertically oriented tube. The system is then filled and the level of water
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in the vertical tube is observed. Next, air pressure is applied to the chamber in order
to produce a pressure change in the water. This pressure change can be calculated by
using a catheter to measure pressure in the chamber. The change in volume can be
found by measuring the change in water height in the tube. These two factors can be
used with Equation 2.3 to calculate the compliance of the membrane.
2.3.3 Tank Compliance Elements
The ankle compliance of the mock circulation system is represented as an open
tank. For an open tank, ∆V = A∆h and ∆P = ρg∆h, this allows for Equation 2.3 to
be represented by Equation 2.5 below.
C =
A
ρg
(2.5)
where A is the area of the open tube, ρ is the fluid density, and g is acceleration
due to gravity [33]. For the system, the tank is created by using a vertical section
of tubing. By using different diameters of tubing,the area of the tank is varied, and
the compliance of the ankle can be adjusted. Fine tuning overall compliance for the
lower leg can be performed by changing the compliance of the ankle air chamber. The
3
8
in tube part of which is circled in Figure 2.7 is open to atmosphere and is a tank
compliance element in the mock circulatory system.
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Figure 2.7: Tank compliance
2.4 Muscle Pump Signal
In venous circulation, pressure in the saphenous vein is dominated by the calf
muscle pump [33]. The configuration shown in Figure 2.8 is used in order to replicate
a physiologically accurate muscle pump. The muscle pump is simulated here by using
a compliant, in-line latex tube housed within a closed air chamber as described in
Section 2.3.2. An alternating high to low pressure is applied to the flexible compliance
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Figure 2.8: Mock circuit muscle pump configuration
element chamber by the position of a flow control valve (MAC Model ISO 3, MAC
VALVES, Wixom, MI). The control valve position is determined by a time-based
voltage signal from the data acquisition system (NI USB-6211 and NI LabVIEW 8.6,
National Instruments, Austin, TX). By adjusting duty ratio, input pressure, and
period of pumping the shape of the pressure signal can be adjusted in order to create
a physiological input which simulates calf muscle action.
2.5 Test Section
In order to determine system baselines, a variety of test sections are used.
They are placed in the location marked ‘‘Test Section” in Figure 2.3. When taking
baseline measurements, all other system parameters are kept constant while data for
each test section is recorded.
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2.5.1 No Valve
In order to simulate a missing or incompetent valve, a straight tube test section
is used as shown in Figure 2.9. The test section is a simple tube connector which has
identical resistance to forward and backward flow. The test section has resistance due
to the length of the connector.
(a) Picture of test section (b) Circuit representation of test section
Figure 2.9: No valve test section
Figure 2.9b shows a circuit representation of this test section where RNoV alve
is a small value due to the length of the test section. This allows for chronic venous
insufficiency due to reflux to be simulated.
2.5.2 Gate Valve
In order to simulate an ideal venous valve, which has no reflux flow rate once
fully closed, a gate valve is used as shown in Figure 2.10. The valve features a swinging
gate which opens during forward flow, but closes during back flow.
Figure 2.10b shows a circuit representation of the test section where Rvalve is
the resistance the flow experiences passing through the valve, and the diode represents
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(a) Picture of test section (b) Circuit representation of test section
Figure 2.10: Gate valve test section
the one directional flow through the valve. The lack of regurgitant flow through the
valve after it has closed allows for an ideal venous valve to be simulated.
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2.5.3 Biological Valve
In order to simulate a biological valve, a bovine jugular vein segment with an
intact valve is used as a test section and is shown in Figure 2.11. The 12 mm intact
valve is contained in a vein segment. The segment is placed inside a piece of hose
to constrain its expansion, and attached with hose barbs to the system. Biological
valves used should be in the appropriate size range for the femoral vein, approximately
12mm [34].
(a) Picture of test section (b) Circuit representation of test section
Figure 2.11: Bovine jugular vein valve test section
Figure 2.11b shows a circuit representation where Rfor represents the resistance
the flow experiences as it travels forward through the valve, and Rback represents the
resistance the flow experiences as it travels backwards through the valve. The two
branches with diodes in opposite direction shown in Figure 2.11b simulate differing
the resistances between forward and backward flow that characterizes a valve which
has reflux when closed. The bovine test section is attached to hose barbs and inserted
into the mock circulatory system. This allows for physiologically healthy venous flow
to be simulated.
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2.5.4 Thrombosis
In order to simulate deep vein thrombosis, a ball valve as a resistance element
is inserted into the system as shown in Figure 2.12.
(a) Picture of test section (b) Circuit representation of test section
Figure 2.12: Thrombosis test section
Figure 2.12b shows a circuit representation of this test section where Rhigh is a
large value created by a valve resistance. The high resistance created by this valve
simulates an acute venous thrombosis or obstruction and allows for chronic venous
insufficiency due to these pathologies to be simulated.
2.6 Uncertainty Analysis of Key Results
Elemental uncertainties are combined using a root mean squared method as
shown in Equation 2.6.
ux = ±
√√√√ K∑
k=1
u2k (2.6)
where ux is the combined uncertainty in a measured of x which is subject to K
different elemental uncertainties, uk is the individual error for k = 1, 2, . . . , K. For
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calculated values, propagation of uncertainty is found using sequential perturbation
[35]. Each uncertainty is reported at a 95% level of confidence.
2.7 Measurements
2.7.1 Pressure Measurement
Pressure is measured in the system using pressure transducers (BD DTX
PlusTM,BD Medical Systems, Sandy, Utah). Pressure taps are placed throughout the
circuit to allow for pressure to be taken at various locations. Pressure can be measured
at any point in the system by attaching a pressure transducer to a local pressure tap.
The pressure transducers are attached to amplifiers which are connected to the
data acquisition board. The excitation voltage of the transducer and the maximum
saturation of the data acquisition, or DAQ, board are both 10 volts. Transducer
output is a differential voltage in mV, so it is amplified in order to utilize the full
range of the DAQ board. The amplifier also allows the signal to be calibrated in order
to counteract drift. Data acquisition software is used in order to convert the voltage
to mmHg. In order to set up the null zero of the transducers, the transducer is opened
to atmosphere and the trim is adjusted until the voltage being reads zero. Next, the
gains are adjusted in order to calibrate the transducer signal to a known pressure.
For air pressure measurement, the transducer is calibrated for pressure measurements
in the working liquid, and the pressure line is cleared of all fluids. The quantization
error of the system is 76 µV [35]
The uncalibrated uncertainty in the pressure measurement is ±2% of the
reading or ±1 mmHg whichever is bigger as given in Appendix B. At a nominal
pressure of 88 mmHg, the uncertainty in pressure is ±1.76 mmHg. However, with
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calibration, this uncertainty can be reduced. Uncertainty in pressure is found by
combining instrument uncertainty, datum uncertainty, and first order uncertainty
[35]. The Nth order uncertainty for pressure measurement is found to be ±0.25mmHg
(95%) [35]. Calculation of uncertainty is found in the code shown in Appendix C.1.
2.7.2 Flow Rate Measurement
In order to measure flow, a flow probe (P600 Flow Probe and FM 501 Square-
Wave Electromagnetic Blood Flowmeter, Carolina Medical Electronics, East Bend,
NC) is placed in the system where the flow rate is desired. The grounding clip is
attached near the flow probe in order to decrease noise. The flow probe will not
function properly without increasing the conductivity of the water. In order to increase
conductivity, regular table salt is mixed into the fluid to allow for the flow probe to
take accurate measurements.
The measured flow signal was zeroed at a zero flow rate, and the sensitivity of
the probe was set using the manufacturer supplied flow probe factor. Finally the gain
in the data acquisition software is set in order to convert the signal to an output of
mL
s
.
The uncertainty from the flow probe is ±2 mV for pulsatile flow as given by
Appendix B. For an output range of 1 V, the uncertainty in flow rate is ±0.2%. For
a nominal flow rate of 13 mL
s
, the uncertainty is ±0.026 mL
s
(95%).
2.8 Operation of System
In order to operate the system, the measurement devices are calibrated and
placed in the system. Pressure taps can be added at any node in the system, and
catheters can be used to measure pressure at points where a tap cannot be inserted
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directly. Next, compressed air sources are turned on, the MAC valve is powered up,
and data acquisition software is initialized. At this point, the pump can be turned
on which provides flow to the constant pressure head tank. The system should be
allowed to run for several minutes before measurements are taken. This allows for
variations in pressure and flow present at start up to dissipate. In operation of the
mock circulatory system, the effects of inertance are considered negligible. In order
to consistently record data, an initial delay can be set where the system is saving
information and the muscle pump is not active, then the number of muscle pump
cycles can be set, and the total save time can be set. Figure 2.13 shows a complete
diagram of the venous mock circulatory system while Figure 2.14 shows a picture of
the complete system in the lab.
Figure 2.13: Venous mock circuit
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Number Component
1. Pivc
2. Rivc
3. Cfem
4. Rfem
5. Test Section
6. Cmp
7. Csve
8. Rsve
9. Csveg
10. Vvn
11. Rvn
Table 2.2: Circuit legend
Figure 2.14: Venous mock circuit in lab
2.9 Tuning of System
In order to tune the system, the system is operated as discussed in Section 2.8
for the no valve test section, the ideal venous valve test section, and the thrombosis
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test section. For each test section, the muscle pump is activated until steady state
is reached, and then the system is allowed to return to steady state. The data is
analysed, so that total pressure drop, and recovery time are found for the test section.
If the parameters lie within acceptable boundaries as outlined in Section 1.2, then
the next test section is analysed. If the parameters are outside of the desired range,
then system parameters are tuned and the test is repeated until the values are within
the allowable range. This is repeated for each test section, until the parameters of
interest are within the acceptable range for each test section. Once the system has
been successfully tuned, the biological test section can be evaluated and analyzed.
2.10 System Parameters
In order to confirm system parameters, the system is operated as discussed
in Section 2.8. For resistance parameters, the system is placed into steady flow by
replacing the tank compliance, Csveg, with a constant pressure head tank lower than
Pivc. This allows for flow to travel consistently through each resistance element in the
system. The flow probe is moved so it is in-line with each resistance element being
measured, and the pressure is measured across each element. The resistance across the
element can then be found using Equation 2.1. Once data has been collected for each
resistance element, the resistance for each element can be found using the code found
in Appendix C.2. The compliance of the air chambers is found using Equation 2.4,
and the compliance of the open tank compliance element is found using Equation 2.5.
The pressure of the head tank, Pivc, is an input, and is found by measuring the
height of the head tank. Uncertainty of system parameters are found using sequential
perturbation [35]. Calculation of uncertainty is shown in code found in Appendix C.2,
and calculation of compliance values is found in Appendix C.3
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2.11 Pressure Verification
Pressure verification is performed by running the system as discussed in
Section 2.8. The flow probe is placed in line with the test section, and pressure
is measured at the ankle as indicated in Figure 2.3. By adjusting muscle pump
function as outlined in Section 2.4, and by operating the system as outlined in
Section 2.8, pressure verification data can be collected and is analysed using code
shown in Appendix C.4. Uncertainty of ankle pressure is found by combining elemental
errors from measurement, and error from linearization of the model as described in
Section 2.1 [26,35]. Pressure measured in this section represents pressure with regard
to a datum at the heart [1]. During pressure verification, the system is not at steady
state, as the total volume in the system changes during muscle pumping and recovery.
2.12 Fluid Volume Moved Per Cycle
Fluid volume moved per cycle, a parameter which is of clinical interest, can
be found by integrating the measured flow rate during each cycle. The system is
run as discussed in Section 2.11, and integration is performed using code shown in
Appendix C.4. Uncertainty in fluid volume moved per cycle is found using sequential
perturbation and is also calculated using code found in Appendix C.4 [35].
2.13 Valve Parameters
2.13.1 Test Section Resistance Values
Valve resistance values are found in a manner similar to system resistance
parameters, as outlined in Section 2.10. The flow probe is placed in-line with the test
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section, and the pressure is measured across the test section. For the biological valve,
the valve is inserted facing downstream to measure its forward resistance, Rfor, and
inserted facing upstream to measure its backwards resistance, Rback. Once data is
gathered, the resistance for each test section can be found using the code found in
Appendix C.2. Uncertainty of test section resistance values are found using sequential
perturbation as described in Section 2.6 [35]. Calculation of uncertainty is also shown
in code found in Appendix C.2.
2.13.2 Reflux Leakage Flow Rate
Reflux leakage flow rate is the flow rate through the valve that occurs when
the valve is fully closed and the pressure upstream of the valve is higher than the
pressure downstream. This occurs when the system is run as shown in Figure 2.14 and
described in Section 2.11. When the muscle pump turns off, and pressure is returning
to steady state, the reflux leakage flow rate is recorded by the flow probe. Uncertainty
in reflux leakage flow rate is due to uncertainty in flow measurement as outlined in
Section 2.7.
2.13.3 Initial Opening Pressure Gradient
In order to find initial opening pressure of a valve, a different test setup is
used. The valve is set between two constant pressure head tanks and pressure taps
are set at each end of the valve. The head tanks start at the same pressure, and
the low pressure head tank is lowered incrementally until a flow probe in the system
shows that the valve has opened. The transvalvular pressure differential at which flow
begins is the initial opening pressure gradient. Figure 2.15 displays the test circuit
for finding the initial opening pressure gradient, and the code used to find opening
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pressure is shown in Appendix C.5. Uncertainty of initial opening pressure gradient is
found using sequential perturbation as described in Section 2.6 [35]. Calculation of
uncertainty is also shown in code found in Appendix C.5.
Figure 2.15: Opening pressure gradient test circuit in lab
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Chapter 3
Results and Discussion
3.1 System Parameters
After the system has been tuned to have an appropriate physiological response
to muscle pumping for all baseline test sections as described in Section 2.9, the values
of the lumped parameter elements shown in Figure 2.3 are found. The values for
circuit parameters are shown in Table 3.1. Each uncertainty shown is at a 95% level
of confidence.
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Parameter Value
Pivc 88.12± 0.25
Pmp 215.6± 0.25
Csveg 0.97± 0.10
Csve 0.66± 0.081 Quantity Unit
Cfem 1.91± 0.019 Pressure mmHg
Cmp 0.18± 0.019 Compliance mLmmHg
Resistance mmHg s
mL
Rsve 1.3± 0.21
Rfem 13.5± 0.25
Rivc 0.6± 0.25
Rvn 18.2± 0.17
Table 3.1: Parameters for mock venous circulatory system
3.2 Pressure Verification
The primary information of interest is how the pressure in the mock circulatory
system responds to simulated exercise. In order to determine pressure response, data
is recorded for 200 seconds. The first 5 seconds the system is at rest, then the muscle
pump is on for 100 seconds with a frequency of 1 Hz in order to simulate exercise.
At 105 seconds, the exercise input turns off, and the system is allowed to return to
steady state.
Figure 3.1 displays pressure and normalized pressure signals for all valves
during the length of the experiment, during muscle pumping only, and during recovery
only, for all test sections. Normalized pressure is found by dividing the pressure at
every point by steady state pressure for the system. During the delay period, pressure
is at steady state. Then the muscle pump turns on for 100 cycles. This causes pressure
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(a) Pressure (b) Normalized Pressure
(c) Pressure during pumping (d) Normalized pressure during pumping
(e) Pressure during recovery (f) Normalized pressure during recovery
Figure 3.1: Dynamic pressure of all test sections
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fluctuation throughout pumping. When the muscle pump is turned off, the pressure
returns to steady no flow pressure.
Figure 3.2 shows the average of each cycle in order to more clearly see trends.
The values are found by averaging pressure across the 1 second muscle pump cycle.
The figures display how there is an initial period of pressure change, pressure increase
for thrombosis and pressure drop for all other test sections. After an initial change, the
pressure reaches steady state where it is maintained until the end of pumping. Once
the muscle pump shuts off, the pressure returns to rest condition. The differences in
ambulatory venous pressure are related to the relative resistance of the system. The
muscle pump is attempting to move a volume of fluid, and this change in volume
causes a corresponding change in pressure. Resistance as described in
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(a) Pressure (b) Normalized Pressure
(c) Pressure during pumping (d) Normalized pressure during pumping
(e) Pressure during recovery (f) Normalized pressure during recovery
Figure 3.2: Average dynamic pressure of all test sections
46
3.2.1 No Valve
The first pressure verification test section is a straight tube test section which
simulates an incompetent or missing valve. Figure 3.3 shows the dynamic pressure
signal of the ankle with the straight tube test section inserted into the femoral vein.
This test section corresponds to a patient with CVI resulting from missing
valves or sever reflux. As discussed in Section 1.2 and shown in Figure 1.8 and
Figure 1.10, initial ankle pressure, when there is no flow, should be between 80
and 90 mmHg, the pressure drop during calf exercise should be < 50%, and the
recovery time should be < 20 s [1, 4]. As shown in Figure 1.9 the system should reach
steady state after approximately 10 tip-toe maneuvers [1]. The initial pressure of
the no valve test section is 89.4 ± 0.25 mmHg (95%), which lies within the range
defined by Eberhardt and Raffetto. The pressure at the end of muscle pumping is
68.5± 0.56 mmHg (95%) which represents a pressure drop of 24% which lies within
the proscribed range [4].
Recovery takes 7.2 ± 0.74 seconds (95%) which is less than the 20 s limit
described by Eberhardt and Raffetto [4]. Figure 3.4 shows the average of each cycle
in order to more clearly see trends. Figure 3.4d shows the average pressure in the
ankle during exercise. Note that the pressure has dropped 17% after 10 cycles and
dropped 22% after 20 cycles. This agrees with the idea found in Meissner et al. that
the majority of pressure drop occurs during the first 10 cycles. The AVP of 68.5mmHg
is in a range that suggests a high risk of ulceration [1].
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(a) Pressure (b) Normalized Pressure
(c) Pressure during pumping (d) Normalized pressure during pumping
(e) Pressure during recovery (f) Normalized pressure during recovery
Figure 3.3: Dynamic pressure of no valve test section
48
(a) Pressure (b) Normalized Pressure
(c) Pressure during pumping (d) Normalized pressure during pumping
(e) Pressure during recovery (f) Normalized pressure during recovery
Figure 3.4: Average dynamic pressure of no valve test section
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3.2.2 Gate Valve
The second pressure verification test section is a gate valve test section which
simulates ideal venous flow. Figure 3.5 shows the dynamic pressure signal of the ankle
with the gate valve test section inserted into the femoral vein.
This test section corresponds to an ideal venous valve which severely limits the
regurgitant flow. As discussed in Section 1.2 and shown in Figure 1.7, initial ankle
pressure, when there is no flow, should be between 80 and 90 mmHg, the pressure
drop during calf exercise should be > 50%, and the pressure recovery time should
be > 20 s [1, 4, 13]. As shown in Figure 1.9 the system should reach steady state
after approximately 10 tip-toe maneuvers [1]. The initial pressure of the gate valve
test section is 89.4 ± 0.25 mmHg (95%) which lies within the physiological range
defined by Eberhardt and Raffetto. The pressure at the end of muscle pumping is
6.7± 0.56 mmHg (95%) which represents a pressure drop of 93% which is > 50% as
described by Eberhardt and Raffetto for a physiological system. Due to the lack of
reflux flow, the pressure drops below the 20 and 30 mmHg range typically seen in
physiological systems [4]. This puts ambulatory venous pressure in a range which
corresponds to a reduced risk of ulceration [1].
Recovery takes 40.0± 0.91 seconds (95%), which lies within the physiological
range [4]. Figure 3.6 shows the average of each cycle in order to more clearly see
trends. Figure 3.6d shows the average pressure in the ankle during exercise note that
the pressure has dropped 40% after 10 cycles and dropped 80% after 20 cycles. This
agrees with the idea found in Meissner et al. that the majority of pressure drop occurs
during the initial period [1].
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(a) Pressure (b) Normalized Pressure
(c) Pressure during pumping (d) Normalized pressure during pumping
(e) Pressure during recovery (f) Normalized pressure during recovery
Figure 3.5: Dynamic pressure of gate valve test section
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(a) Pressure (b) Normalized Pressure
(c) Pressure during pumping (d) Normalized pressure during pumping
(e) Pressure during recovery (f) Normalized pressure during recovery
Figure 3.6: Average dynamic pressure of gate valve test section
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3.2.3 Biological Valve
The next pressure verification test section is a bovine jugular vein valve test
section which simulates healthy venous flow. Figure 3.7 shows the dynamic pressure
signal of the ankle with the bovine jugular vein valve inserted into the femoral vein.
This test section corresponds to a healthy biological valve. As discussed in
Section 1.2 and shown in Figure 1.7, initial ankle pressure, when there is no flow,
should be between 80 and 90 mmHg, the pressure drop during calf exercise should
be > 50% and lie in a range between 20 and 30 mmHg, and the pressure recovery
time should be > 20 s [1, 4, 13]. As shown in Figure 1.9 the system should reach
steady state after approximately 10 tip-toe maneuvers [1]. The initial pressure of
the biological valve test section is 89.4 ± 0.25 mmHg (95%) which lies within the
physiological range defined by Eberhardt and Raffetto. The pressure at the end of
muscle pumping is 19.8± 0.56 mmHg (95%) which represents a pressure drop of 78%
which is > 50% as described by Eberhardt and Raffetto for a physiological system [4].
This puts ambulatory venous pressure in a range which corresponds to a reduced risk
of ulceration [1].
Recovery takes 23.7± 0.72 seconds (95%), which lies within the physiological
range [4]. Figure 3.8 shows the average of each cycle in order to more clearly see
trends. Figure 3.8d shows the pressure in the ankle during exercise note that the
pressure has dropped 32% after 10 cycles and dropped 65% after 20 cycles. This
agrees with the idea found in Meissner et al. that the majority of pressure drop occurs
during the initial exercise period [1].
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(a) Pressure (b) Normalized Pressure
(c) Pressure during pumping (d) Normalized pressure during pumping
(e) Pressure during recovery (f) Normalized pressure during recovery
Figure 3.7: Dynamic pressure of biological valve test section
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(a) Pressure (b) Normalized Pressure
(c) Pressure during pumping (d) Normalized pressure during pumping
(e) Pressure during recovery (f) Normalized pressure during recovery
Figure 3.8: Average dynamic pressure of biological valve test section
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3.2.4 Thrombosis
The next pressure verification test section is a high resistance test section
which simulates an acute deep vein thrombosis or a deep vein obstruction. Figure 3.9
shows the dynamic pressure signal of the ankle with the high resistance test section
inserted into the femoral vein.
This test section corresponds to an acute deep vein thrombosis. As discussed in
Section 1.2, thrombosis causes pressure to rise during calf pump function [14,15]. The
initial pressure of the thrombosis test section, when there is no flow, is 89.4±0.25 mmHg
(95%). The pressure at the end of muscle pumping is 99.2± 0.56 mmHg (95%) which
represents a pressure increase of 10%. This pressure increase is a physiological response
to exercise as described by Negle´n and Raju, and Comerota [14,15]. Recovery takes
0.70± 0.16 seconds (95%). Figure 3.10a shows the average of each cycle in order to
more clearly see trends.
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(a) Pressure (b) Normalized Pressure
(c) Pressure during pumping (d) Normalized pressure during pumping
(e) Pressure during recovery (f) Normalized pressure during recovery
Figure 3.9: Dynamic pressure thrombosis test section
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(a) Pressure (b) Normalized Pressure
(c) Pressure during pumping (d) Normalized pressure during pumping
(e) Pressure during recovery (f) Normalized pressure during recovery
Figure 3.10: Average dynamic pressure of thrombosis test section
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3.3 Fluid Volume Moved Per Cycle
The fluid pumped through the test section each cycle is found by numerically
integrating the flow rate for each pump cycle using the trapezoid method. The volume
moved per cycle is higher during the transient stage when the pump is first activated,
and the pressure is approaching ambulatory venous pressure. Once the system has
reached steady state and pressure has reached AVP the fluid volume moved per cycle
decreases. The volume moved per cycle for each test section is displayed in Figure 3.11.
(a) No valve (b) Gate valve
(c) Biological valve (d) Thrombosis
Figure 3.11: Fluid volume moved per cycle for each test section
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As shown in Section 1.2, a maximum flow rate of between 10--13mL
s
is a
physiological flow volume for a patient with healthy venous flow [11]. The maximum
flow rate is 13mL
s
for the gate valve, and the maximum flow rate for the biological
valve is 11.5mL
s
, as shown in Table 3.2. Both are within the physiological range
prescribed for healthy venous flow during exercise [11]. Each uncertainty shown is at
a 95% level of confidence.
Test Section Maximum [mL] Steady State [mL]
No Valve 5.4± 0.026 2.8± 0.026
Gate Valve 13.0± 0.026 5.9± 0.026
Biological Valve 11.5± 0.026 5.5± 0.026
Thrombosis 0.5± 0.026 0.5± 0.026
Table 3.2: Fluid volume moved per cycle
3.4 Valve Parameters
Test section resistance values are found as outlined in Section 2.13.1 and are
displayed in Table 3.3. RNoV alve is resistance of the no valve test section as shown in
Figure 2.9. Rvalve is the resistance of the gate valve test section as seen in Figure 2.10.
Rfor and Rback are the forward and backward resistances of the biological vein valve
as shown in Figure 2.11. Rhigh is the resistance of the thrombosis test section as seen
in Figure 2.12. Reflux leakage flow rate is the flow rate through the valve once it is
closed as described in Section 2.13.2.
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Resistor Resistance [mmHg s
mL
]
RNoV alve 0.29± 0.16
Rvalve 0.59± 0.19
Rfor 0.38± 0.18
Rback 0.39± 0.18
Rhigh 4.62± 0.17
Table 3.3: Test section resistance values
As can be seen in Figure 3.12 and Table 3.4, throughout recovery, the flow
rate remains at zero. This demonstrates how the gate valve is an ideal valve with no
regurgitant flow once the valve is fully closed. Each uncertainty shown is at a 95%
level of confidence.
Figure 3.12: Reflux flow rate and recovery pressure for gate valve test section
Test Section Reflux Flow Rate [mL
s
] Initial Opening Pressure Gradient [mmHg]
Gate Valve 0.0± 0.026 0.73± 0.25
Biological Valve 3.2± 0.026 0.72± 0.25
Table 3.4: Test section reflux flow rate and initial opening pressure gradient
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For the biological valve, as can be seen in Figure 3.13, immediately after
pumping, the reflux flow rate spikes to a maximum of 3.2 ± 0.026 mL
s
(95%) and
leakage continues until steady state is reached. This reflux flow rate is rather high for
physiological flow, however pressure drop experienced by the system, and the slow
recovery time shown in Section 3.2 are still within the physiological range defined in
Section 1.2 [4].
DeLaria et al., Zervides and Constantinos, Sathe, Pavnik et al. and Rittgers
et al., among others have all suggested that valve competence under physiological
conditions should be considered a primary indicator of whether a valve can successfully
address CVI [5,7,20--25]. As can been seen in Figure 3.8, even with the high reflux
rate of the biological valve, it still reduces AVP to 19.8 mmHg, which is low enough
to reduce risk of ulceration [1]. This suggests that reflux flow rate may not be an
appropriate indicator of valve performance when AVP is of primary concern. This
suggests that even valves which may have a fairly high reflux rate may have success
in reducing ulceration in patients, and that merely testing valve parameters will not
give a good an appropriate idea of physiological valve performance. In order to fully
test prosthetic valves in an in vitro setting, a LPM of venous circulation is a better
approach as it allows for AVP and recovery time, the parameters of clinical interest,
to be determined.
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Figure 3.13: Reflux flow rate and recovery pressure for biological valve test section
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Chapter 4
Conclusions
4.1 Conclusions
This system is the first in vitro test circuit for prosthetic vein valves which
measures ambulatory venous pressure as a response to exercise across a wide range of
physiological conditions. The system is able to model physiological response with a
competent vein valve similar to the test circuit as described by Moriyama et al. [6]. .
Unlike the test circuit described by Moriyama et al., the test circuit described here is
also capable of reproducing physiological pressure signals for deep vein thrombosis
and for highly incompetent or missing venous valves [6]. This system also accurately
reproduces physiological flow rates, pressure drop times, and pressure recovery times
in conjunction with accurate pressure signals. These factors contribute to create an
effective way to evaluate new prosthetic vein valve designs.
This is the first time physiologically accurate flow rates, ambulatory venous
pressures and pressure recovery times have all been simulated in a single mock
circulatory system. This means that the physiological effects of new prosthetic vein
valves can be evaluated in vitro, before testing in vivo. Previous research relied on
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valve parameters such as reflux leakage, valve opening time, and valve closing time in
order to determine candidate valves for implantation. This mock circuit allows for the
valve’s effects on ambulatory venous pressure to be analysed so that the effectiveness
of the valve for ulcer prevention can be determined prior to more expensive and more
difficult in vivo testing.
Many other groups which have created in vitro test systems for prosthetic vein
valves have used reflux flow rate as a primary indicator of valve success [5, 7, 20--25].
However, the results of testing the biological valve, as shown in Section 3.4, indicate
that reflux flow rate may not be a good indicator of valve performance. The high
reflux flow rate found for the biological valve and the AVP drop of > 50% as shown
in Section 3.2 indicate that a test section with a high reflux flow rate will be able to
produce an ambulatory venous pressure which is low enough to significantly reduce
risk of ulcer formation [1].
4.2 Recommendations for Future Work
The first recommendation for future work is to find ways to reduce inertance
effects on implementation of the test circuit. Recall from Section 2.8, the inertance of
the system is considered negligible, however in reality this is very difficult to achieve.
Inertance errors during pressure verification are not apparent with the gate valve and
the biological valve, however the thrombosis test section and no valve test section
appear to have some errors due to inertance. Figure 4.1 displays the average pressure
signals for the thrombosis test section and the no valve test section and highlights the
areas where inertance effects are evident. When the muscle pump is first turned off,
inertance in the tank compliance causes the pressure change. This sharp change is
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circled in Figure 4.1. For a thrombosis test section, inertance causes a sharp pressure
drop, while for a no valve test section, inertance causes a sharp pressure rise.
(a) Thrombosis test section (b) No valve test section
Figure 4.1: Highlighted inertance effects on pressure
In order to further improve the mock circuit, a superficial venous branch can be
added to the deep venous branch currently in the system as shown in Figure 4.2 [30].
The addition of a superficial branch with perforating veins will increase accuracy of
the system and allow for the effects of superficial reflux and thrombosis to be analysed
in addition to the conditions which can currently be tested. The system can also be
improved by using laminar resistance elements. Now that resistance values have been
found which give physiological results, laminar resisters can be constructed for the
known resistance values which will improve system accuracy.
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Figure 4.2: Venous network with superficial branch and perforating veins: From
Fragomeni et al. [30]
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Another way to improve the system would be to make the mock circuit more
compact. By shortening the tube connections between system components, the overall
fluid volume of the system can be reduced. This will allow the overall fluid volume of
the system to more closely match the fluid volume found in the leg.
Another area where the mock circuit could be improved is by using biologically
compatible materials. By replacing components in the system with biologically friendly
materials, biological valves can be better tested.
Another area of future research is the importance of reflux flow rate on ambu-
latory venous pressure. This can be analyzed by testing more biological valves with a
variety of reflux flow rates. Reflux flow rates are typically discussed in relation to
a high ambulatory venous pressure, but there may be other disadvantages to reflux
flow rate such as energy dissipation or increased thrombosis. These other effects of
high reflux flow rate must be analyzed in order to achieve a more complete picture of
how valve reflux effects chronic venous disease. Testing of biological venous valves,
as outlined in Section 3.4, suggest that reflux flow rate does not have a major impact
on the reduction of ambulatory venous pressure. This suggests that fluid diodes, as
described by Camp, which do not close to prevent flow, but have a higher resistance
to back flow than forward flow may be a solution to chronic venous insufficiency [36].
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Appendix A Process Factor Calculation
Figure A.1 shows the circuit for calculating the process factor. The MAC valve
uses input data from Labview to control the application of vacuum and compressed
air to the berlin heart. This creates the flow for the circuit. Some of the flow enters
and then leaves the air chamber. This flow and change in pressure are measured with
the pressure transducer and flow probe. The flow that does not travel into the air
chamber bypasses the compliance element and returns to the atrium head tank. This
allows enough fluid to remain in the head tank for the circuit to run continuously.
Figure A.1: Process factor testing circuit
The process factor in Equation 2.4 is based upon the type of process that
produces the change in compliance. For an isothermal process, the process factor is
1. For an isentropic process, the process factor would be the heat capacity ratio of
standard air, or 1.4. The pulsatile flow value for the process factor was determined
experimentally. In order to run this experiment, the Equations 2.3 and 2.4 are
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combined to solve for the process factor based on the experimental and theoretical
compliances of an air chamber experiencing pulsatile flow. This is shown in the
Equation A.1 below.
n =
∀∆P
Pabs∆V
(A.1)
where Pabs is absolute atmospheric pressure. The change in air pressure was measured
at the pressure sensor and the volumetric flow rate into and out of the air chamber
was measured at the flow probe. The volumetric flow rate is integrated to find change
in volume. Change in volume, change in pressure, volume of trapped air, and value
for absolute pressure are used with Equation A.1 to find the process value [32].
The factors shown in Table A.1 are calculated using the code displayed in
Section A.1, and a sample of the data used to find the process factor is found in
Section A.2. The test statistic means that with a confidence level of 99 %, it cannot
be shown that the process factor differs statistically from 1.
Process Factor Standard Deviation Test Statistic
n std t0
1.0026 2.9269 0.0156
Table A.1: Statistical analysis of process factor
A.1 Process Factor Code
clear
clc
close all
%%
% Time
dat=load('CT 15.txt');
Q=dat(:,1);
N=length(Q);
M=320;
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t=[0:M-1]'/M*2;
Qea=zeros(M,1);
ncyc=N/M;
for k=0:ncyc-1
Qea=Qea+Q(k*M+[1:M]');
end
Test1(:,1)=Qea;
%%
% Volume
Q=dat(:,7);
N=length(Q);
M=320;
t=[0:M-1]'/M*2;
Qea=zeros(M,1);
ncyc=N/M;
for k=0:ncyc-1
Qea=Qea+Q(k*M+[1:M]');
end
Qea=Qea*60;
Test1(:,2)=Qea;
%%
% Pressure
Q=dat(:,2);
N=length(Q);
M=320;
t=[0:M-1]'/M*2;
Qea=zeros(M,1);
ncyc=N/M;
for k=0:ncyc-1
Qea=Qea+Q(k*M+[1:M]');
end
Test1(:,3)=Qea;
%%
% Signal
Q=dat(:,4);
N=length(Q);
M=320;
t=[0:M-1]'/M*2;
Qea=zeros(M,1);
ncyc=N/M;
for k=0:ncyc-1
Qea=Qea+Q(k*M+[1:M]');
end
Test1(:,4)=Qea;
%%
Test1=Test1/ncyc;
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i1=length(Test1);
tt=((Test1(3,1)-Test1(2,1))+(Test1(2,1)-Test1(1,1)))/2;
%%
ab=0.5;
V1(1,1)=0;
for i=2:1:i1-1
%V1(i,1)=V1(i-1)+(Test1(i,2)+ab)*tt;
%delV1(i,1)=(V1(i,1)-V1(i-1,1));
delV1(i,1)=Test1(i,2)*tt;
delP1(i,1)=Test1(i,3)-Test1(i-1,3);
time1(i,1)=Test1(i,1)-Test1(1,1);
signal1(i,1)=Test1(i,4);
end
%%
C1=delV1./delP1;
subplot(2,1,2),plot(time1,C1,time1,signal1)
title('Data Set 1 Combined Graph');
xlabel('Time [s]');
ylabel('Pressure [mmHg] or Compliance [mL/mmHg]');
legend('Compliance [mL/mmHg]','Pressure [mmHg]')
subplot(2,1,1),plot(time1,C1)
title('Data Set 2 Compliance');
xlabel('Time [s]');
ylabel('Compliance [mL/mmHg]');
C1=C1(isfinite(C1));
Ca1=trimmean(C1,25);
figure
plot(Test1(:,1)-Test1(1,1),Test1(:,2)/60,Test1(:,1)-Test1...
(1,1),Test1(:,3),Test1(:,1)-Test1(1,1),Test1(:,4))
title('Data Set 1 Pressure and Flow');
xlabel('Time [s]');
ylabel('Pressure [mmHg] or Flowrate [mL/s]');
legend('Flowrate [mL/s]','Pressure [mmHg]','Input Pressure [...
mmHg]')
plot(time1,delP1,time1,delV1)
title('Change in Pressure and Change in Volume Over Time');
xlabel('Time [s]')
legend('delP','delV')
V=44*10ˆ2*pi/4;
C=V/(760+1.4);
%n=C/Ca1;
p=length(C1);
for i=1:1:p
nm(i)=C/C1(i);
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end
n=trimmean(nm,50);
std=std(nm);
N=length(nm);
t0=(n-1)/(std/sqrt(N));
A.2 Sample of Process Factor Data
X Value Thoracic Pressure Pulsatile Flow sig 6
0 −28.404386 −131.210535 0.000662
0.00625 −27.623018 −139.431998 0.000333
0.0125 −26.7351 −146.666885 −0.000325
0.01875 −25.758391 −154.230631 0.000333
0.025 −24.692889 −161.465518 −0.000325
0.03125 −23.574113 −168.371547 0.000333
0.0375 −22.446457 −174.948717 −0.000325
0.04375 −21.363197 −180.210453 0.000662
0.05 −20.368729 −185.801048 0.000333
0.05625 −19.480811 −190.733925 −0.000654
0.0625 −18.717202 −195.666803 0.000333
0.06875 −18.122297 −200.599681 4.02E − 06
0.075 −17.678338 −204.545983 4.02E − 06
0.08125 −17.394204 −208.492285 0.000333
0.0875 −17.252137 −211.452011 0.000333
0.09375 −17.181104 −211.78087 4.02E − 06
0.1 −16.914728 −211.452011 0.000333
0.10625 −16.044569 −210.794294 4.02E − 06
0.1125 −13.815895 −207.505709 4.02E − 06
0.11875 −9.429581 −201.915115 −0.000325
0.125 −2.139774 −195.666803 −0.000325
0.13125 8.248868 −186.787623 4.02E − 06
0.1375 21.301267 −175.606434 0.000662
0.14375 35.978562 −164.096386 4.02E − 06
0.15 50.780175 −150.942046 4.02E − 06
0.15625 64.23216 −135.156837 −0.000325
0.1625 75.206857 −119.700487 4.02E − 06
0.16875 83.135992 −101.613268 0.000333
0.175 88.12611 −81.552899 −0.000325
Table A.2: Sample of process factor data
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Appendix B Instrument Documentation
B.1 Data Acquisition Board
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NI USB-621x Specifications
Specifications listed below are typical at 25 °C unless otherwise noted. Refer to the NI USB-621x User Manual for more 
information about USB-621x devices. 
Caution The input/output ports of this device are not protected for electromagnetic interference due to functional 
reasons. As a result, this device may experience reduced measurement accuracy or other temporary performance 
degradation when connected cables are routed in an environment with radiated or conducted radio frequency 
electromagnetic interference.
To ensure that this device functions within specifications in its operational electromagnetic environment and to limit radiated 
emissions, care should be taken in the selection, design, and installation of measurement probes and cables.
Analog Input
Number of channels
USB-6210/6211/6212/
6215/6216................................... 8 differential or 
16 single ended
USB-6218................................... 16 differential or 
32 single ended
ADC resolution ............................... 16 bits
DNL ................................................ No missing codes 
guaranteed
INL.................................................. Refer to the AI Absolute 
Accuracy Tables
Sampling rate
Maximum
USB-6210/6211/6215/6218 ... 250 kS/s single channel, 
250 kS/s multichannel 
(aggregate)
USB-6212/6216 ..................... 400 kS/s single channel, 
400 kS/s multichannel 
(aggregate)
Minimum.................................... 0 S/s
Timing accuracy ......................... 50 ppm of sample rate
Timing resolution ....................... 50 ns
Input coupling ................................. DC
Input range.......................................±10 V, ±5 V, 
±1 V, ±0.2 V
Maximum working voltage for analog inputs
(signal + common mode).................±10.4 V of AI GND
CMRR (DC to 60 Hz) .....................100 dB
Input impedance
Device on
AI+ to AI GND ......................>10 GΩ in parallel 
with 100 pF
AI– to AI GND.......................>10 GΩ in parallel 
with 100 pF
Device off
AI+ to AI GND..................1200 Ω
AI– to AI GND ..................1200 Ω
Input bias current.............................±100 pA
Crosstalk (at 100 kHz)
Adjacent channels .......................–75 dB
Non-adjacent channels ................–90 dB
Small signal bandwidth (–3 dB)
USB-6210/6211/6215/6218 ........450 kHz
USB-6212/6216 ..........................1.5 MHz
ni.com/manuals
DeutschFrançais
NI USB-621x Specifications 2 ni.com
Input FIFO size................................4,095 samples
Scan list memory .............................4,095 entries
Data transfers...................................USB Signal Stream, 
programmed I/O
Overvoltage protection (AI <0..31>, AI SENSE)
Device on ....................................±30 V for up to 
two AI pins
Device off ...................................±20 V for up to 
two AI pins
Input current during 
overvoltage condition ......................±20 mA max/AI pin
Settling Time for Multichannel Measurements
Accuracy, full scale step, all ranges
USB-6210/6211/6215/6218
±90 ppm of step (±6 LSB)......4 μs convert interval
±30 ppm of step (±2 LSB)......5 μs convert interval
±15 ppm of step (±1 LSB)......7 μs convert interval
USB-6212/6216
±90 ppm of step (±6 LSB)......2.5 μs convert interval
±30 ppm of step (±2 LSB)......3.5 μs convert interval
±15 ppm of step (±1 LSB)......5.5 μs convert interval
Typical Performance Graphs
USB-6210/6211/6215/6218
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Analog Output
Number of channels
USB-6210................................... 0
USB-6211/6212/6215/
6216/6218................................... 2
DAC resolution ............................... 16 bits
DNL ................................................ ±1 LSB
Monotonicity................................... 16 bit guaranteed
Maximum update rate
1 channel..................................... 250 kS/s
2 channels ................................... 250 kS/s per channel
Timing accuracy ............................. 50 ppm of sample rate
Timing resolution............................ 50 ns
Output range ................................... ±10 V
Output coupling .............................. DC
Output impedance ........................... 0.2 Ω
Output current drive........................ ±2 mA
Overdrive protection ....................... ±30 V
Overdrive current ............................ 2.4 mA
Power-on state................................. ±20 mV
Power-on glitch............................... ±1 V for 200 ms
Output FIFO size ............................ 8,191 samples shared 
among channels used
Data transfers .................................. USB Signal Stream, 
programmed I/O
AO waveform modes:
• Non-periodic waveform
• Periodic waveform regeneration mode from onboard FIFO
• Periodic waveform regeneration from host buffer including 
dynamic update
Settling time, full scale step
15 ppm (1 LSB) .............................. 32 μs
Slew rate ......................................... 5 V/μs
Glitch energy
Magnitude................................... 100 mV
Duration...................................... 2.6 μs
Calibration (AI and AO)
Recommended warm-up time ......... 15 minutes
Calibration interval ......................... 1 year
NI USB-621x Specifications
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AI Absolute Accuracy Table (USB-6210/6211/6215/6218)
Nominal Range
Residual 
Gain Error 
(ppm of 
Reading)
Gain 
Tempco 
(ppm/°C)
Reference 
Tempco
Residual 
Offset 
Error 
(ppm of 
Range)
Offset 
Tempco 
(ppm of 
Range/°C)
INL Error    
(ppm of 
Range)
Random 
Noise, σ 
(μVrms)
Absolute 
Accuracy 
at Full 
Scale1 (μV)
Sensitivity2 
(μV)
Positive 
Full Scale
Negative 
Full Scale
10 –10 75 7.3 5 20 34 76 229 2,690 91.6
5 –5 85 7.3 5 20 36 76 118 1,410 47.2
1 –1 95 7.3 5 25 49 76 26 310 10.4
0.2 –0.2 135 7.3 5 40 116 76 12 88 4.8
AbsoluteAccuracy = Reading · (GainError) + Range · (OffsetError) + NoiseUncertainty
GainError = ResidualAIGainError + GainTempco · (TempChangeFromLastInternalCal) + ReferenceTempco · (TempChangeFromLastExternalCal)
OffsetError = ResidualAIOffsetError + OffsetTempco · (TempChangeFromLastInternalCal) + INL_Error
1
 Absolute accuracy at full scale on the analog input channels is determined using the following assumptions:
TempChangeFromLastExternalCal = 10 °C
TempChangeFromLastInternalCal = 1 °C
number_of_readings = 100
CoverageFactor = 3 σ
For example, on the 10 V range, the absolute accuracy at full scale is as follows:
GainError = 75 ppm + 7.3 ppm · 1 + 5 ppm · 10 GainError = 132 ppm
OffsetError = 20 ppm + 34 ppm · 1 + 76 ppm OffsetError = 130 ppm
AbsoluteAccuracy = 10 V · (GainError) + 10 V · (OffsetError) + NoiseUncertainty AbsoluteAccuracy = 2,690 μV
2
 Sensitivity is the smallest voltage change that can be detected. It is a function of noise.
Accuracies listed are valid for up to one year from the device external calibration.
NoiseUncertainty RandomNoise 3⋅
100
-----------------------------------------= For a coverage factor of 3 σ and averaging 100 points.
NoiseUncertainty 229 μV 3⋅
100
--------------------------= NoiseUncertainty 68.7 μV=
©
 National Instrum
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AI Absolute Accuracy Table (USB-6212/6216)
Nominal Range
Residual 
Gain Error 
(ppm of 
Reading)
Gain 
Tempco 
(ppm/°C)
Reference 
Tempco
Residual 
Offset 
Error 
(ppm of 
Range)
Offset 
Tempco 
(ppm of 
Range/°C)
INL Error    
(ppm of 
Range)
Random 
Noise, σ 
(μVrms)
Absolute 
Accuracy 
at Full 
Scale1 (μV)
Sensitivity2 
(μV)
Positive 
Full Scale
Negative 
Full Scale
10 –10 75 7.3 5 20 34 76 295 2,710 118.0
5 –5 85 7.3 5 20 36 76 149 1,420 59.6
1 –1 95 7.3 5 25 49 76 32 310 12.8
0.2 –0.2 135 7.3 5 40 116 76 13 89 5.2
AbsoluteAccuracy = Reading · (GainError) + Range · (OffsetError) + NoiseUncertainty
GainError = ResidualAIGainError + GainTempco · (TempChangeFromLastInternalCal) + ReferenceTempco · (TempChangeFromLastExternalCal)
OffsetError = ResidualAIOffsetError + OffsetTempco · (TempChangeFromLastInternalCal) + INL_Error
1
 Absolute accuracy at full scale on the analog input channels is determined using the following assumptions:
TempChangeFromLastExternalCal = 10 °C
TempChangeFromLastInternalCal = 1 °C
number_of_readings = 100
CoverageFactor = 3 σ
For example, on the 10 V range, the absolute accuracy at full scale is as follows:
GainError = 75 ppm + 7.3 ppm · 1 + 5 ppm · 10 GainError = 132 ppm
OffsetError = 20 ppm + 34 ppm · 1 + 76 ppm OffsetError = 130 ppm
AbsoluteAccuracy = 10 V · (GainError) + 10 V · (OffsetError) + NoiseUncertainty AbsoluteAccuracy = 2,710 μV
2
 Sensitivity is the smallest voltage change that can be detected. It is a function of noise.
Accuracies listed are valid for up to one year from the device external calibration.
NoiseUncertainty RandomNoise 3⋅
100
-----------------------------------------= For a coverage factor of 3 σ and averaging 100 points.
NoiseUncertainty 295 μV 3⋅
100
--------------------------= NoiseUncertainty 88.5 μV=
NI USB-621x Specifications
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AO Absolute Accuracy Table
Nominal Range
Residual Gain 
Error (ppm of 
Reading)
Gain Tempco 
(ppm/°C)
Reference 
Tempco
Residual 
Offset Error 
(ppm of 
Range)
Offset Tempco 
(ppm of 
Range/°C)
INL Error          
(ppm of 
Range)
Absolute 
Accuracy at 
Full Scale1 
(μV)
Positive 
Full Scale
Negative 
Full Scale
10 –10 90 11 5 60 12 128 3,512
1
 Absolute Accuracy at full scale numbers is valid immediately following internal calibration and assumes the device is operating within 10 °C of the last external calibration. 
Accuracies listed are valid for up to one year from the device external calibration.
AbsoluteAccuracy = OutputValue · (GainError) + Range · (OffsetError)
GainError = ResidualGainError + GainTempco · (TempChangeFromLastInternalCal) + ReferenceTempco · (TempChangeFromLastExternalCal)
OffsetError = ResidualOffsetError + AOOffsetTempco · (TempChangeFromLastInternalCal) + INL_Error
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Digital I/O/PFI
Static Characteristics
Number of channels
Digital input
USB-6210/6211/6215 ............ 4 (PFI <0..3>/P0.<0..3>)
USB-6218 .............................. 8 (PFI <0..3>/P0.<0..3>, 
PFI <8..11>/P0.<4..7>)
Digital output
USB-6210/6211/6215 ............ 4 (PFI <4..7>/P1.<0..3>)
USB-6218 .............................. 8 (PFI <4..7>/P1.<0..3>, 
PFI <12..15>/P1.<4..7>)
Digital input or output
USB-6212/6216 
Screw Terminal...................... 32 total, 16 (P0.<0..15>), 
16 (PFI <0..7>/P1.<0..7>, 
PFI <8..15>/P2.<0..7>)
USB-6212/6216 
Mass Termination/BNC......... 24 total, 8 (P0.<0..7>), 
16 (PFI <0..7>/P1.<0..7>, 
PFI <8..15>/P2.<0..7>)
Ground reference ............................ D GND
Pull-down resistor
USB-6210/6211/6215/6218........ 47 kΩ ±1%
USB-6212/6216.......................... 50 kΩ typical, 
20 kΩ minimum
Input voltage protection1................. ±20 V on up to 8 pins
PFI Functionality
USB-6210/6211/6215/6218
PFI <0..3>, PFI <8..11>/Port 0
Functionality .......................... Static digital input, 
timing input
Debounce filter settings ......... 125 ns, 6.425 μs, 
2.56 ms, disable; 
high and low transitions; 
selectable per input
PFI <4..7>, PFI <12..15>/Port 1
Functionality .......................... Static digital output, 
timing output
Timing output sources ........... Many AI, AO, 
counter timing signals
USB-6212/6216 PFI <0..15>
Functionality............................... Static digital input, 
static digital output, 
timing input, 
timing output
Timing output sources ................Many AI, AO, 
counter timing signals
Debounce filter settings ..............125 ns, 6.425 μs, 
2.56 ms, disable; 
high and low transitions; 
selectable per input
Maximum Operation Conditions
Digital Input Characteristics 
(USB-6210/6211/6215/6218)
Digital Input Characteristics (USB-6212/6216)
Digital Output Characteristics 
(USB-6210/6211/6215/6218)
1   Stresses beyond those listed under Input voltage protection may cause permanent damage to the device.
Level Min Max
IOL output low current — 16 mA
IOH output high current — –16 mA
Level Min Max
VIL input low voltage
VIH input high voltage
0 V
2 V
0.8 V
5.25 V
IIL input low current (Vin = 0 V)
IIH input high current (Vin = 5 V)
—
—
–10 μA
120 μA
Level Min Max
VIL input low voltage
VIH input high voltage
0 V
2.2 V
0.8 V
5.25 V
IIL input low current (Vin = 0 V)
IIH input high current (Vin = 5 V)
—
—
–10 μA
250 μA
Positive-going threshold (VT+) — 2.2 V
Negative-going threshold (VT–) 0.8 V —
Delta VT hysteresis (VT+ – VT–) 0.2 V —
Parameter Voltage Level Current Level
VOL 0.6 V 6 mA
VOH 2.7 V –16 mA
3.8 V –6 mA
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Digital Output Characteristics (USB-6212/6216) General-Purpose Counter/Timers
Number of counter/timers ............... 2
Resolution ....................................... 32 bits
Counter measurements.................... Edge counting, 
pulse, 
semi-period, 
period, 
two-edge separation
Position measurements ................... X1, X2, X4 quadrature 
encoding with 
Channel Z reloading; 
two-pulse encoding
Output applications ......................... Pulse, pulse train with 
dynamic updates, 
frequency division, 
equivalent time sampling
Internal base clocks......................... 80 MHz,
20 MHz,
0.1 MHz
External base clock frequency ........ 0 MHz to 20 MHz
Base clock accuracy........................ 50 ppm
Inputs .............................................. Gate, Source, HW_Arm, 
Aux, A, B, Z, Up_Down
Routing options for inputs
USB-6210/6211/6215/6218 ....... PFI <0..3>, PFI <8..11>, 
many internal signals
USB-6212/6216.......................... PFI <0..15>, 
many internal signals
FIFO................................................ 1,023 samples
Data transfers .................................. USB Signal Stream, 
programmed I/O
Frequency Generator
Number of channels ........................ 1
Base clocks ..................................... 10 MHz, 100 kHz
Divisors........................................... 1 to 16
Base clock accuracy........................ 50 ppm
Output can be available on any output PFI terminal.
–50
–45
–40
–35
–30
–25
–20
–15
–10
–5
0
2 3 4 5 6
Voh (V)
I oh
 
(m
A)
PFI <0..15>/P0.<0..15>: Ioh versus Voh
0 °C; Vdd = 5.5 V
55 °C; Vdd = 4.5 V
25 °C; Vdd = 5.0 V
0
5
10
15
20
25
30
35
40
0 0.2 0.4 0.6 0.8 1 1.2
Vol (V)
I ol
 
(m
A)
PFI <0..15>/P0.<0..15>: Iol versus Vol
0 °C; Vdd = 5.5 V
55 °C; Vdd = 4.5 V
25 °C; Vdd = 5.0 V
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External Digital Triggers
Source
USB-6210/6211/6215/6218........ PFI <0..3>, PFI <8..11>
USB-6212/6216.......................... PFI <0..15>
Polarity............................................ Software-selectable 
for most signals
Analog input function ..................... Start Trigger, 
Reference Trigger, 
Pause Trigger, 
Sample Clock, 
Convert Clock, 
Sample Clock Timebase
Analog output function ................... Start Trigger, 
Pause Trigger, 
Sample Clock, 
Sample Clock Timebase
Counter/timer functions .................. Gate, Source, HW_Arm, 
Aux, A, B, Z, Up_Down,
Bus Interface
USB................................................. USB 2.0 Hi-Speed or 
Full-Speed1
USB Signal Stream (USB).............. 4, can be used for analog 
input, analog output, 
counter/timer 0, 
counter/timer 1
Power Limits
+5 V terminal as output2
Voltage ....................................... 4.6 to 5.2 V
Current (internally limited) ........ 50 mA max, shared 
with digital outputs
+5 V terminal as input2
Voltage ....................................... 4.75 to 5.35 V
Current........................................ 350 mA max, 
self-resetting fuse
Caution Do not exceed 16 mA per DIO pin.
Protection.................................... ±10 V
Power Requirements
Input voltage on USB-621x 
USB port..........................................4.5 to 5.25 V in 
configured state
Maximum inrush current .................500 mA
No load typical current ....................320 mA at 4.5 V
Maximum load
Typical current............................400 mA at 4.5 V
Suspend current...........................260 μA, typical
Physical Characteristics
Enclosure dimensions (includes connectors)
USB-621x Screw Terminal.........16.9 × 9.4 × 3.1 cm 
(6.65 × 3.70 × 1.20 in.)
USB-621x Mass Termination .....19.3 × 9.4 × 3.1 cm 
(7.61 × 3.68 × 1.20 in.)
USB-621x BNC ..........................23.5 × 11.2 × 6.4 cm 
(9.25 × 4.40 × 2.50 in.)
Weight
USB-621x Screw Terminal.........206 g (7.2 oz)
USB-6212 Mass Termination .....227 g (8.0 oz)
USB-6216 Mass Termination .....231 g (8.1 oz)
USB-6212/6216/6218 BNC........950 g (33.5 oz)
USB-6210 OEM .........................73 g (2.5 oz)
USB-6212/6216/6218 OEM .......76 g (2.6 oz)
I/O connectors
USB-6210/6211/6215 .................Two 16-position 
combicon
USB-6212/6216/6218
Screw Terminal...........................Four 16-position 
combicon
USB-6212/6216
Mass Termination .......................One 68-pin SCSI
USB-6212/6216/6218 BNC........19 BNCs and 
26 screw terminals
USB connector ................................Series B receptacle
Screw terminal wiring .....................16 to 28 AWG
Torque for screw terminals .............0.22–0.25 N · m 
(2.0–2.2 lb · in.)
1   If you are using a USB M Series device in Full-Speed mode, device performance will be lower and you will not be able to 
achieve maximum sampling/update rates.
2   USB-621x Screw Terminal/BNC devices have a self-resetting fuse that opens when current exceeds this specification. 
USB-621x Mass Termination devices have a user-replaceable socketed fuse that opens when current exceeds this specification. 
Refer to the NI USB-621x User Manual for information about fuse replacement.
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Environmental
Operating temperature.....................0 to 45 °C
Storage temperature.........................–20 to 70 °C
Humidity..........................................10 to 90% RH, 
noncondensing
Maximum altitude ...........................2,000 m
Pollution Degree
(indoor use only) .............................2
Maximum Working Voltage1
USB-6210/6211/6212 Rated Voltage
Channel-to-earth ground..................11 V, 
Measurement Category I
Caution Do not use for measurements within 
Categories II, III, or IV.
USB-6215/6216/6218 Rated Voltage
Channel-to-earth ground2
Continuous ..................................≤60 VDC, 
Measurement Category I3
Withstand ....................................≤1000 Vrms, 
verified by a 5 s 
dielectric withstand test
Analog channel to AI GND/AO GND 
(in Figure 1, Va – Vc)...................≤11 V, 
Measurement Category I3
Digital channel to D GND 
(in Figure 1, Vb – Vc) ......................≤5.25 V, 
Measurement Category I3
Caution This device is rated for Measurement 
Category I and the voltage across the isolation 
barrier is limited to no greater than 30 Vrms/
60 VDC/42.4 Vpk continuous. Do not use for 
measurements within Categories II, III, or IV.
Figure 1 illustrates the maximum working voltage 
specifications.
Figure 1.  USB-6215/6216/6218 Maximum Working Voltage
Safety
This product meets the requirements of the following 
standards of safety for electrical equipment for measurement, 
control, and laboratory use:
• IEC 61010-1, EN 61010-1
• UL 61010-1, CSA 61010-1 
Note For UL and other safety certifications, refer 
to the product label or the Online Product 
Certification section.
Electromagnetic Compatibility
This product meets the requirements of the following EMC 
standards for electrical equipment for measurement, control, 
and laboratory use:
• EN 61326 (IEC 61326): Class A emissions; 
Basic immunity
• EN 55011 (CISPR 11): Group 1, Class A emissions
• AS/NZS CISPR 11: Group 1, Class A emissions
• FCC 47 CFR Part 15B: Class A emissions
• ICES-001: Class A emissions
1   Maximum working voltage refers to the signal voltage plus the common-mode voltage.
2   In Figure 1, Va – Vd, Vb – Vd, and Vc – Vd.
3   Measurement Category I is for measurements performed on circuits not directly connected to the electrical distribution system 
referred to as MAINS voltage. MAINS is a hazardous live electrical supply system that powers equipment. This category is 
for measurements of voltages from specially protected secondary circuits. Such voltage measurements include signal levels, 
special equipment, limited-energy parts of equipment, circuits powered by regulated low-voltage sources, and electronics.
Isolated Front End USB Connector
Isolation Barrier
AI x/AO x Va
Vb PFI x 
Vc AI GND/AO GND/D GND 
Vd
Ve
Bus
Bus
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Note For the standards applied to assess the EMC 
of this product, refer to the Online Product 
Certification section. 
Note For EMC compliance, operate this product 
according to the documentation.
Note For EMC compliance, operate this device 
with shielded cables.
CE Compliance
This product meets the essential requirements of applicable 
European Directives as follows:
• 2006/95/EC; Low-Voltage Directive (safety)
• 2004/108/EC; Electromagnetic Compatibility Directive 
(EMC)
Online Product Certification
Refer to the product Declaration of Conformity (DoC) for 
additional regulatory compliance information. To obtain 
product certifications and the DoC for this product, visit 
ni.com/certification, search by model number or 
product line, and click the appropriate link in the Certification 
column.
Environmental Management
NI is committed to designing and manufacturing products in 
an environmentally responsible manner. NI recognizes that 
eliminating certain hazardous substances from our products is 
beneficial to the environment and to NI customers.
For additional environmental information, refer to the NI and 
the Environment Web page at ni.com/environment. This 
page contains the environmental regulations and directives 
with which NI complies, as well as other environmental 
information not included in this document.
Waste Electrical and Electronic Equipment (WEEE)
EU Customers At the end of their life cycle, all 
products must be sent to a WEEE recycling center. 
For more information about WEEE recycling 
centers and National Instruments WEEE initiatives, 
visit ni.com/environment/weee.htm.
⬉ᄤֵᙃѻક∵ᶧ᥻ࠊㅵ⧚ࡲ⊩˄Ё೑ RoHS˅
Ё೑ᅶ᠋ National Instrumentsヺড়Ё೑⬉ᄤֵ
ᙃѻકЁ䰤ࠊՓ⫼ᶤѯ᳝ᆇ⠽䋼ᣛҸ (RoHS)Ǆ݇Ѣ
National InstrumentsЁ೑ RoHSড়㾘ᗻֵᙃˈ
䇋ⱏᔩ ni.com/environment/rohs_chinaǄ
(For information about China RoHS compliance, 
go to ni.com/environment/rohs_china.)
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Figure 2.  USB-6210 Pinout Figure 3.  USB-6211/6215 Pinout
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7
8
1
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4
13
14
15
16
9
10
11
12
AI 1
AI 9
AI 2
AI 10
AI 3
AI 11
AI SENSE
AI 4
AI 12
AI 5
AI 13
AI GND
AI 6
AI 14
AI 7
AI 15
PFI 0/P0.0 (In)
PFI 1/P0.1 (In)
PFI 2/P0.2 (In)
PFI 3/P0.3 (In)
D GND
PFI 4/P1.0 (Out)
PFI 5/P1.1 (Out)
PFI 6/P1.2 (Out)
PFI 7/P1.3 (Out)
+5 V
D GND
NC
NC
RESERVED
AI 0
AI 8
21
22
23
24
17
18
19
20
29
30
31
32
25
26
27
28
NC = No Connect
5
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7
8
1
2
3
4
13
14
15
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9
10
11
12
AI 1
AI 9
AI 2
AI 10
AI 3
AI 11
AI SENSE
AI 4
AI 12
AI 5
AI 13
AI GND
AI 6
AI 14
AI 7
AI 15
PFI 0/P0.0 (In)
PFI 1/P0.1 (In)
PFI 2/P0.2 (In)
PFI 3/P0.3 (In)
D GND
PFI 4/P1.0 (Out)
PFI 5/P1.1 (Out)
PFI 6/P1.2 (Out)
PFI 7/P1.3 (Out)
+5 V
D GND
AO 0
AO 1
AO GND
AI 0
AI 8
21
22
23
24
17
18
19
20
29
30
31
32
25
26
27
28
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Figure 4.  USB-6212/6216 Screw Terminal Pinout Figure 5.  USB-6212/6216 Mass Termination Pinout
AI 1
AI 9
AI 2
AI 10
AI 3
AI 11
AI SENSE
AI 4
AI 12
AI 5
AI 13
AI GND
AI 6
AI 14
AI 7
AI 15
PFI 0/P1.0
PFI 1/P1.1
PFI 2/P1.2
PFI 3/P1.3
D GND
PFI 4/P1.4
PFI 5/P1.5
PFI 6/P1.6
PFI 7/P1.7
+5 V
D GND
AO 0
AO 1
AO GND
AI 0
AI 8
5
6
7
8
1
2
3
4
13
14
15
16
9
10
11
12
21
22
23
24
17
18
19
20
29
30
31
32
25
26
27
28
D GND
P0.4
P0.5
P0.6
P0.7
D GND
P0.8
P0.9
P0.10
P0.11
D GND
P0.12
P0.13
P0.14
P0.15
D GND
PFI 8/P2.0
PFI 9/P2.1
PFI 10/P2.2
PFI 11/P2.3
D GND
PFI 12/P2.4
PFI 13/P2.5
PFI 14/P2.6
PFI 15/P2.7
+5 V
D GND
P0.0
P0.1
P0.2
P0.3
D GND
5
6
7
8
1
2
3
4
13
14
15
16
9
10
11
12
21
22
23
24
17
18
19
20
29
30
31
32
25
26
27
28 60
59
58
57
64
63
62
61
52
51
50
49
56
55
54
53
44
43
42
41
48
47
46
45
36
35
34
33
40
39
38
37
PFI 14/P2.6
PFI 12/P2.4
PFI 9/P2.1
D GND
PFI 6/P1.6
PFI 5/P1.5
D GND
+5 V
D GND
PFI 1/P1.1
PFI 0/P1.0
D GND
D GND
+5 V
D GND
P0.6
P0.1
D GND
P0.4
NC
AO 1
AO 0
AI 15
AI GND
AI 6
AI 13
AI GND
AI 4
AI GND
AI 3
AI 10
AI GND
AI 1
AI 8
D GND
PFI 8/P2.0
PFI 7/P1.7
PFI 13/P2.5
PFI 4/P1.4
PFI 3/P1.3
PFI 2/P1.2
D GND
PFI 15/P2.7
D GND
PFI 10/P2.2
PFI 11/P2.3
P0.3
P0.7
P0.2
D GND 
P0.5
P0.0
D GND
AO GND
AO GND
AI GND
AI 7
AI 14
AI GND
AI 5
AI 12
AI SENSE
AI 11
AI GND
AI 2
AI 9
AI GND
AI 0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
TERMINAL 1
TERMINAL 34
TERMINAL 35
TERMINAL 68
NC = No Connect
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Figure 6.  USB-6212/6216 BNC Pinout
NI USB-6212/6216
AI x + 
AI x –
GS
0.1 µF 5 kΩ
AI GND
FS
+
–
USB-621x Device
Floating
Source
AI x + 
AI x –
GS
0.1 µF 5 kΩ
AI GND
FS
+
–
USB-621x Device
Ground-
Referenced
Source
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Figure 7.  USB-6218 Screw Terminal Pinout
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AI 10
AI 3
AI 11
AI SENSE
AI 4
AI 12
AI 5
AI 13
AI GND
AI 6
AI 14
AI 7
AI 15
PFI 0/P0.0 (In)
PFI 1/P0.1 (In)
PFI 2/P0.2 (In)
PFI 3/P0.3 (In)
D GND
PFI 4/P1.0 (Out)
PFI 5/P1.1 (Out)
PFI 6/P1.2 (Out)
PFI 7/P1.3 (Out)
+5 V
D GND
AO 0
AO 1
AO GND
AI 0
AI 8
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AI 20
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AI 23
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PFI 8/P0.4 (In)
PFI 9/P0.5 (In)
PFI 10/P0.6 (In)
PFI 11/P0.7 (In)
D GND
PFI 12/P1.4 (Out)
PFI 13/P1.5 (Out)
PFI 14/P1.6 (Out)
PFI 15/P1.7 (Out)
+5 V
D GND
NC
NC
AI GND
AI 16
AI 24
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NC = No Connect
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Figure 8.  USB-6218 BNC Pinout
NI USB-6218
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Source
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Blood Flow Probes 
CAROLINA MEDICAL ELECTRONICS, INC 
4125 Old Mill Road, East Bend, North Carolina 27018 USA, 
Phone (336) 983-5132 Fax (336) 699-3305 
 
100 Series 
This miniature probe is for low flow 
measurements in small animals and 
rodents. 
 
These very small probes have been used 
on the carotid, femoral and renal arteries  
of small animals, including rodents such  
as 300 gram rats. Excellent pulsatile and 
mean flow recordings have been obtained 
in such applications. 
 
The 100 Series Probe is designed only 
for use with the CME Model 500 Series 
Flowmeters.  
 
Both the acute and chronic probes are 
available with: (I) The cable angle as 
shown, (2) Right angle cable (see page 5), 
and (3) Side angle cable (see page 5). 
Please specify your choice. 
 
Dowel slot closures for chronic probes are 
cut from solid silicone rods. A length of 
rod is provided with each probe from 
which several closures can be cut. 
 
The chronic probe cable can be fabricated 
with: (1) A dual silicone sheath to provide 
maximum flexibility but with an implant 
life of approximately two weeks, or (2) A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
dual sheath of internal vinyl and an 
external silicone material to make the 
cable slightly less flexible but with a much 
longer implant life. Please specify your 
choice. Both cables have an O.D. of 
approximately 2.6 mm. 
 
Acute probes terminate in a standard PV8 
Connector (see page 7). Chronic probes 
terminate in: (1) A miniature PSP 
Connector (with nylon protective cap), (2) 
A "Saddle Connector" which can be 
sutured in place at the shoulders, or (3) A 
specially designed connector (optional at 
extra cost). Please specify your choice. 
 
A special 180 cm adapter/extension 
cable (CA-523) is recommended for use 
with all acute and chronic probes. 
 
Standard Sizes for Acute and Chronic 
Probes: 
1-4 mm internal circumference in l/2 mm     
increments ONLY for CME Model 501 
Flowmeter (Analog Panel Meter). 
4-10 mm internal circumference in !/2 mm 
increments for CME Models 501 and 
501D Flowmeters. 
 
Acute cable length—60 cm. 
Chronic cable length—30 cm (or to 
customer specifications). 
 
When extremely low flow measurements 
are encountered in acute studies, an 
occlusive zero may be required. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
200 Series 
This forceps probe is for acute 
flow measurements in most arties 
and veins.  Its design makes it 
particularly well suited for use on 
diseased vessels. 
 
The forceps probe provides good 
sensitivity with maximum versatility 
of application and removal.  It may 
be easily rotated and positioned to 
obtain the best anatomical 
orientation, yet with minimum 
vessel disturbance.  The probe can 
be hand held and gentle pressure on 
the finger grips will snap-lock the 
probe securely around the vessel. 
Measurements are quickly obtained 
with either right or left hand 
positioning.  The handle is non-
metallic and measures 12 cm 
(excluding the probe head). 
 
Standard Sizes for Acute Probes: 
6-20 mm internal circumference in 2 
mm increments. 
20-125 mm internal circumference in 
5 mm increments. 
Acute cable length—180 cm.  
 
Non-standard probe sizes and cable 
lengths are available. Please contact 
factory 
 
Recommended Starter Sets for CME   
701D Flowmeter (CLINIFLOW II): 
Peripheral Set: SF218, SF220, SF225, 
    SF230 and SF235. 
Thoracic Set: SF270, SF275, SF280, 
     SF285 and SF290 
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300A Series 
 
An extracorporeal probe for flow measurement in bypass or 
perfusion applications. 
 
It is an improved version of a time- tested design which has been 
used clinically and in research for many years with excellent results. 
The new version has reduced mass and weight for increased 
durability. For ease of installation into the flow line, the tubing 
connectors are of the threaded, self-clamping type. (The 1/16” size 
has a non-threaded cannula.) 
 
Extracorporeal probes provide maximum signal and stability because 
the blood makes direct contact with the sensing electrodes. 
Calibration curves indicate significantly less variation in sensitivity 
attributable to blood hematocrit change than is experienced with 
extravascular probes. Many researchers use an extracorporeal probe 
as a reference probe in calibrating and standardizing the 
extravascular probes.  
 
Measurements as low as 1 ml/mm are possible using the l/16”I.D. 
size under optimum conditions. This indicates the high degree of 
stability and sensitivity provided by this type of probe. The tubing 
connectors are made from a single piece of smooth bore nylon. Sizes 
are specified according to the I.D. of the tubing connectors (cannula). 
 
Standard 
Sizes 
1/16” 1/8” 1/4” 3/8” 1/2” 
Cannula 
I.D. 
1/16” 
1.6 mm 
1/8” 
3.2 mm 
1/4” 
6.4 mm 
3/8” 
9.5 mm 
1/2” 
12.7 mm 
Nominal 
Cannula 
Length 
2 ¾“ 
7 cm 
2 ¾“ 
7 cm 
2 ¾“ 
7 cm 
2 ¾“ 
7 cm 
2 ¾“ 
7 cm 
Nominal 
Flow 
Range Per 
Minute 
5 ml 
To 
150 ml 
25 ml 
To 
500 ml 
100 ml 
To 
1 L 
500 ml 
To 
10 L 
500 ml 
To 
20 L 
 
 
Non-Standard sizes are available.  Please contact factory. 
 
Cable length – 180 cm. 
 
 
 
 
 
 
 
 
 
 
 
 
300AP Series 
 
This extracorporeal probe is the same as the 300A 
Series, plus pressure ports. It is recommended where 
pressure measurements, withdrawal of blood samples 
or injections are required. 
 
An outstanding feature is the probe permits monitoring 
blood flow and pressure simultaneously from essentially 
the same measurement site. 
 
The probe is available with single (P1) or dual pressure 
ports (P2). Unless otherwise designated, a single 
pressure port will be on the inflow side of the probe. 
Dual ports permit measuring a differential pressure 
across the point of flow. The nominal interlumenal 
distance between the dual ports is 5-10 mm. The 
stainless steel pressure port has an inside diameter of 
.063 inch (equivalent to a 13 gauge needle) and connects 
to a standard male Becton Dickinson Luer-Lok fitting. 
Caps are supplied for sealing the ports when they are not 
in service. 
 
Sizes: 
 
See 300A Series. 
 
Cable length — 180 cm. 
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400 Series 
 
The configuration and size make it desirable for most acute 
and chronic flow studies. 
 
Minimum physical size and mass, consistent with good 
sensitivity, enhance the versatility of this design. This type of 
probe is the most popular of all series and is used with large 
and small vessels including the ascending aorta aid coronary 
arteries. 
 
A bibliography of scientific papers reports a wide variety of 
applications in research, teaching, laboratory and clinical 
requirements. 
Recent reports cover such diverse applications as measurement 
of cardiac output (ascending aorta and pulmonary artery) in 
evaluating prosthetic valve function, flow measurement in 
selective arteriolization of the coronary vein, and 
determination of regurgitant fraction in aortic insufficiency 
studies. 
 
Publications also report probe implantations in man for 
monitoring internal carotid blood flow during graded occlusion 
for aneurysm, and for monitoring flow after reconstructive 
surgery of the arteries of the lower limb. A comprehensive 
range of sizes and a number of optional features are available 
to meet the wide ranging requirements of individual users. 
 
Standard Sizes for Acute and Chronic Probes: 
 
4-20 mm internal circumference in 2 mm increments. 
20-125 mm internal circumference in 5 mm increments. 
 
Acute cable length—180 cm. 
Chronic cable length—30 cm. 
 
Non-standard probe sizes and cable lengths are available. 
Please contact factory.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
400H Series 
 
Handle type for vein grafts and similar acute applications. 
Features wide slot with a sliding closure. 
 
The opening for the vessel is easily closed by a sliding 
mechanism on the handle. This type is well suited for 
saphenous vein grafts and other procedures involving 
transplanted vessels where external support of the probe during 
measurement is often desirable. An outstanding feature of this 
probe is that it permits rapid measurement of blood flow in 
evaluating a revascularization procedure where time may be a 
pressing factor. 
 
The 12cm handle provides a convenient means of support and 
additional physical stability during flow studies. The wider 
slot, in most sizes, facilitates applications involving 
atherosclerotic vessels. In use, one simply retracts the slider 
and places the probe around the vessel, then returns the slider 
to the closed position. The sliding mechanism may be 
completely removed for cleaning; no tools are required. 
 
Standard Sizes for Acute Probes: 
 
6-20 mm internal circumference in 2 mm increments. 
20-35 mm internal circumference in 5 mm increments. 
 
Acute cable length—l8Ocm. 
 
Non-standard probe sizes and cable lengths are available. 
Please contact factory. 
 
Recommended Coronary Starter Set for CME 701D 
Flowmeter (CLINIFLOW II): SF4O8H, SF4IOH, 
SF4I2H, SF414H and SF4I6H. 
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Options 
 
Right Angle Cable  
 
For application where the anatomical 
situation makes it desirable that the probe 
cable be parallel with the vessel. 
 
The probe is positioned at a right angle 
to the cable which will be parallel to the 
vessel after the probe is in place. This 
enables flow measurement from a vessel 
that would otherwise be inaccessible or 
difficult with other cable positions. It 
has proved successful in many species 
of animals when used as an implantable 
probe. Most researchers prefer this 
series for use on the dog’s aorta, carotid 
and femoral vessels. On subcutaneous 
vessels the right angle cable facilitates 
easier placement of the cable to a 
desirable location some distance away 
from the original incision. This permits 
better healing and is convenient for 
connecting an adapter cable from the 
flowmeter. 
 
Other cable angles may be available 
upon request. Special coronary artery 
probes for use in research applications 
have been constructed as illustrated. 
 
Acute cable length—180 cm.  
Chronic cable length—30 cm. 
 
 
 
Bendable Handle 
For application where flow recordings are 
necessary from a vessel with difficult 
anatomical accessibility or where some 
physical support of the probe is desired 
during measurement. 
 
The semi-flexible handle may be bent 
into any desired shape or configuration. 
A 15 cm section of semi-rigid cable 
extending from the probe head permits 
forming while retaining significant 
stiffness, This assists manipulation 
during use somewhat similar to a 
conventional Handle Probe. There is a  
 
 
 
 
slight increase in the diameter of the 
bendable handle section of the cable. The 
remainder of the cable is the same as other 
probe cables.  The bendable handle was 
designed especially for acute applications 
but may be feasible for certain chronic 
uses. 
 
Available on 400 Series Probes, 6 mm and 
larger. 
 
Acute cable length—180 cm.  
Chronic cable length—30 cm. 
 
 
 
 
Slot Closures 
Chronic probes are supplied with a slot 
closure. The size and series of the probe 
determines the type of closure. Available as 
an option on acute probes 
The following closure types are custom 
fitted to each individual probe.  
Replacement of the closure requires 
returning the probe to the factory. 
 
Dowel 
The closure is secured by a suture to the 
probe cable and is wedged into place to 
retain the vessel. Used on small probes, 
sizes 4-25mm internal circumference. 
 
 
 
Hinged 
Supplied standard on chronic probes of 
30mm internal circumference and larger. 
Built as an integral part of the probe using 
a time-tested proven design. The closure is 
hinged to a pivot pin and securely snaps 
into place under light finger pressure 
without use of forceps or other 
instruments. 
 
 
 
 
 
 
Spring Lock 
The closure snaps into place under light 
pressure and is retained by means of a 
stainless steel spring. This closure 
allows up to a 30% larger slot opening 
and is available upon request for probe 
sizes 30-100mm internal circumference. 
 
 
 
Wrap Around 
This silicone, “wrap around” slot 
closure is pliable and very easy to apply 
and remove. Available only on right 
angle probes in sizes 10-30mm internal 
circumference. 
 
 
 
Suture Eyelets 
In certain applications it is desirable to 
attach sutures for probe stabilization. 
This is primarily in special chronic 
situations. One or more suturing eyelets 
can be provided on most probes. Eyelet 
locations must be specified when 
ordering. 
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600 Series 
 
This probe is for IN VIVO vessel cannulation and 
perfusion of excised organs. 
 
This probe is similar in appearance to the 300A Series but 
it is reduced in weight and mass. It utilizes a smooth bore 
cannula. Available in a wide range of sizes. A probe with a 
6 mm lumen circumference will measure flow of 10 
ml/mm. Variations of this probe can be constructed for 
special research requirements. One such type has been for 
attachment to or near a heart valve for septal defect 
studies. Wall thickness of the cannula is graduated from 
about 1 mm for the smallest size to approximately 2.5 mm 
for the largest size. 
 
Standard Sizes for Acute and Chronic Probes: 
4–20 mm internal circumference in 2 mm increments. 
20–125 mm internal circumference in 5 mm increments. 
 
No-standard sizes and/or modifications for special research 
requirements are available. Please contact factory.  
 
Acute cable length — 180 cm.  
Chronic cable length — 30 cm. 
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Connectors and Cables 
 
 
Connectors 
Carolina Medical Electronics probes 
come equipped with the appropriate 
electrical connector for the series of 
CME flowmeter to be used. Refer to 
General Ordering Information. 
 
 
Non-metallic connectors are of epoxy, 
thus eliminating oxidation problems and 
minimizing moisture absorption. The 
junction of the connector and cable is 
sealed with silicone to provide increased 
moisture protection and added strain  
 
 
relief. All electrical contacts are 
gold plated for maximum reliability. 
Since chronic probe cables are of 
shorter length, an adapter cable will 
be required to connect to the 
flowmeter. 
CONNECTOR DESCRIPTION  
DB17 
Standard connector for acute probes to be used with 
CME 700 Series Flowmeters (CLINIFLOW II).  
Connects directly to flowmeter.  Contains a PROM 
which automatically calibrates the flowmeter for probe 
gain and hematocrit sensitivity 
 
PV8 
Standard connector for acute probes to be used with 
CME 500 Series Flowmeters.  Connects directly to 
flowmeter. 
 
PSP8 
Standard right angle connector for chronic probes.  An 
adaptor cables is required to connect to flowmeter.  
Equipped with two screw-on, nylon, skin washers with 
screw-on, stainless steel cap. 
 
PVT 
Optional connector for chronic probes.  An adapter 
cable is required to connect to flowmeter.  Equipped 
with a protective, screw-on, stainless steel cap.  Skin 
washers are not generally used but are available upon 
request.  
 
Adapter Cables 
 
Chronic probes require an adapter cable for connecting to the 
500 Series Flowmeters. Adapter cables for CME flowmeters 
other than the series listed are available on special order. 
 
 
   * Used also as a probe extension cable for 500 Series Flowmeters. 
* * Recommended for use with the 100 Series Probes and Model 501 
Flowmeter. 
 
Note: Non-standard cable lengths are available. Contact factory 
for quotation. 
 
 
 
 
 
 
 
 
 
Probe Extension Cables 
These cables are used between an acute probe and the 
flowmeter when additional cable length is necessary. Probe 
extension cables for CME flowmeters other than the series 
listed are available on special order. 
 
 
 
 
 
 
 
   * Used also as a probe extension cable for 500 Series Flowmeters. 
* * Recommended for use with the 100 Series Probes and Model 501 
Flowmeter.  Used also as an adapter cable. 
 
Note: Non-standard cable lengths are available. Contact factory 
for quotation. 
Ground Wire – GW- 5 
This is an insulated wire equipped with a plated spring clip. 
The standard length is twelve feet. EP and SF probes must 
be grounded in order to function properly. This is 
accomplished by connecting a ground wire as outlined in the 
flowmeter instruction manual. Two GW-5 Ground Wires are 
supplied with each flowmeter. It is recommended that a 
spare ground wire be kept on hand. 
 
FLOWMETER 
SERIES 
LENGTH 
(FEET) 
CABLE 
NUMBER 
500 
500 
500 
6 
12 
6 
CA-504A* 
CA-509A* 
CA-523 ** 
FLOWMETER 
SERIES 
LENGTH 
(FEET) 
CABLE 
NUMBER 
500 
500 
500 
700 
6 
12 
6 
8 
CA-504A* 
CA-509A* 
CA-523 ** 
CA-701 
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General Ordering 
Information 
 
Preface to Ordering 
• Determine flowmeter model number. 
This enables the factory to insure 
proper electrical connectors and 
wiring. This information is on a metal 
plate attached to the flowmeter and is 
required since all probes are not 
compatible with all flowmeters. 
• Select the probe series having the 
configuration or style best suited for 
the intended application. 
• Determine the probe size. For 
additional information see sections 
“Vessel Fit” and “Vessel 
Measurement” on page 10. 
• Decide if the probe type should be 
acute or chronic. Chronic probes may 
be used for acute applications, 
however acute probes cannot be 
satisfactorily implanted. It is best to 
use probes for their intended purposes. 
• Select any desired options. 
• Select any required or additional 
cables, such as adapter and/or 
extension cables. 
• Please stale flowmeter model 
number with each order. 
 
EP is the prefix for probes used with the 
CME 500 Series Flowmeters. All EP 
series probes are factory calibrated.  
There is no extra charge for calibration 
of EP probes.  
 
SF is the prefix for probes used with 
CME 700 Series Flowmeters 
(CLINIFLOW II). These probes are 
factory calibrated. There is no extra 
charge for calibration of SF probes. 
 
• All orders are filled in accordance with 
instructions in customers purchase 
order. To avoid unnecessary delays 
and/or expense, please contact the 
factory if additional information is 
needed to specify your 
requirements. 
 
PROBES FLOWMETERS 
EP Prefix 500 Series 
SF Prefix 
700 Series 
CLINIFLOW II 
 
 
 
 
 
 
Ordering 100, 200, 400, 
400H and 600 Series Probes 
 
(Please see “Preface to Ordering” section 
first) 
 
1. EP or SF designates the probe prefix for 
the flowmeter to be used. Flowmeter 
model must be stated on order. (The 100 
Series Probe is designed only for use with 
the CME Model 500 Series Flowmeters.) 
 
2. The first numeral designates the probe 
series. (1 for 100 Series, 2 for 200 Series, 
4 for 400 Series, 6 for 600 Series.) 
 
3. The remaining numerals designate the 
size of the probe in mm of internal 
circumference. (Example: 04 for 4 mm 
internal circumference, 50 for 50 mm 
internal circumference, 100 for 100 mm 
internal circumference.) 
 
4. The model number of the probe must be 
followed with any required suffixes to 
specify desired options: 
 
“C” denotes a chronic type probe, 
having a slot closure and a 30 cm 
cable length. 
“H” denotes a handle type probe. 
“R” denotes a right angle cable. 
“S” denotes a side angle cable. 
“BH” denotes a bendable handle.  
 
5. Suturing eyelets can be provided on many 
probes. Eyelet locations must be 
specified; please include sketch. 
 
6. You can use the Flow Probe Order Form 
or use the examples below to place your 
order for Flow Probes. 
 
EXAMPLE: An order for a 100 Series 
Probe with a 7.5mm internal 
circumference, for a chronic application, 
right angle cable, probe cable of vinyl and 
silicone material, miniature PSP Connector, 
and one 180cm adapter/extension cable for 
use with a CME 501 Flowmeter, would be 
written as: 
(One) EP-107.5CR Probe, Vinyl/Silicone 
Cable, Miniature PSP Connector (For use 
with a CME 501 Flowmeter). 
(One) CA-523 Adapter/Extension Cable.  
 
EXAMPLE: An order for a 400H Series 
Handle Probe with a 12 mm internal 
circumference, and one 8 foot extension 
cable for use with a CME 701D Flowmeter 
(CLINIFLO W II), would be written as: 
(One) SF-412H Probe (For use with a CME 
701D Flowmeter). 
(One) CA-701 Extension Cable. 
 
 
 
Ordering 300A and 300AP 
Series Extracorporeal Probes 
 
(Please see “Preface to Ordering” 
section first) 
 
1. EP or SF designates the probe prefix 
for the flowmeter to be used. 
Flowmeter model must be stated on 
order. 
 
2. 300A designates an extracorporeal 
probe without pressure ports. 
 
3. Suffix “Pi” denotes (one) pressure 
port. Suffix “P2” denotes (two) 
pressure ports. 
 
4. The last figures (
1
/16”, ½”, ¾”, etc.) 
designate the inside diameter of the 
probe cannula. 
 
 
EXAMPLE: An order for a 300AP 
Series Probe, with two pressure ports, 
with a ¾” I.D. cannula for use with a 
CME 701D Flowmeter (CLINIFLOW 
II), would be written as: 
(One) SF-300AP2 ¾” Probe, (For use 
with a CME 701D Flowmeter). 
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General Probe 
Features 
 
Ferromagnetic Core for Increased 
Sensitivity 
Electrostatically Shielded 
Encapsulation — Evacuated Unfilled 
Epoxy 
Cables — Miniature, Shielded, Highly 
Flexible, Jacket of Medical Grade 
Silicone Rubber. Extension and 
Chronic Adapter Cables Available 
Connectors – Acute and Chronic 
Types, Gold-Plated Contacts 
Many Optional Features  
Complete Range of Sizes 
Factory Calibrated 
 
Factory repair and technical services 
or provided for all products 
manufactured by Carolina Medical 
Electronics, Inc. 
 
Principle of 
Operation 
 
The principle of operation is based on 
the induction of a voltage in a 
conductor (blood) moving through a 
magnetic field. The voltage will be 
induced at right angles to the direction 
of motion and to the magnetic field. 
The induced voltage’s polarity 
depends upon the polarity of the field 
and the direction of the conductor’s 
motion. Its magnitude is determined 
by the velocity of motion, the strength 
of the field and the length of the 
conductor (cross-section). 
 
 
 
V = vBD microvolts 
V is the induced signal voltage 
B is the magnetic flux density in gauss 
D is the diameter of the vessel in cm 
v is the mean velocity in meters/sec 
 
 
 
 
 
 
 
 
The probe consists basically of an 
electromagnet to produce the field and two 
electrodes which pick up the flow induced 
signal. The electrodes in the extracorporeal 
(cannulating) probes make direct contact 
with the blood. The electrodes in the 
extravascular (non-cannulating) probes 
make contact with the outer surface of the 
vessel wall.  
 
The arrow on conventional probes 
indicates the direction of flow which will 
produce a positive flowmeter output, 
when the probe switch on the flowmeter is 
turned to its (+) position.  
 
There are several types of electromagnetic 
flowmeters. They are normally identified 
according to the waveshape of the 
energizing signal which produces a 
magnetic field in the probe. 
 
CME flowmeters operate on the square-
wave principle which permits effective 
separation of the flow signal from 
undesirable quadrature effects. The quality 
and quantity of the scientific data
1
 obtained 
from CME flowmeters attest to the excellent 
results derived from this system. 
 
Flowmeters must perform several functions 
for the probe. They supply an energizing 
signal to produce the magnetic field. They 
receive the flow induced signal which is 
then amplified and converted to a DC 
voltage proportional to the volumetric flow 
rate. This signal is then made available for 
visual presentation, computation or storage. 
 
The blood flow probes listed in this 
brochure have been designed specifically for 
flowmeters manufactured by Carolina 
Medical Electronics, Inc. 
 
1
 Comprehensive bibliography on blood 
flow studies using CME flowmeters is 
available upon request. 
 
Vessel Fit 
 
Since the probe operates on the principle of 
electromagnetic induction, its output is 
proportional to blood velocity. To measure 
flow volume it is necessary to fix the cross-
sectional area in the probe. (Flow = Velocity 
X Cross-Sectional Area).  Accuracy depends 
on fit. Contact between the electrodes and 
the vessel wall must be maintained at all 
times. Obviously, a probe applied to an 
undersized vessel cannot be accurately 
calibrated since it will not fix the vessel 
cross-section, and its electrodes will not 
make adequate contact to the vessel. If large 
changes in blood pressure are anticipated, 
 
 
 
the probe used must be small enough 
to maintain good contact at the lowest 
pressure. Use of a probe too small will 
alter the arterial pulsatile flow pattern, 
and reduction of the cross-sectional 
area of approximately 50 per cent will 
markedly affect mean flow. 
Investigators have found that area 
reduction up to 20 per cent does not 
substantially alter the pulsatile flow 
pattern. Caution is indicated with 
atherosclerotic vessels. 
 
In chronic applications, it should be 
remembered that the vessel will return 
to its normal state after incision 
closure. The size of the implanted 
probe should be such that the vessel 
will not be excessively constricted 
postoperatively. 
Chronic probes are supplied with a 
slot closure. The type of closure is not 
the same for all sizes and series of 
probes. When selecting a probe style, 
consideration should be given to 
physiological factors such as the 
length of the vessel which can be 
exposed, the space available around 
the vessel, proximity of adjacent 
organs and depth of vessel location. A 
broad selection of probes enables the 
investigator to accommodate 
variations in vessel size and thus 
obtain maximum results from the 
blood flow instrumentation. For 
applications which may require 
deviations from standard styles (i.e. 
cable angle, cable length, special 
eyelets, etc.) please contact the 
manufacturer. 
 
 
Vessel Measurement 
The probe size is specified in 
millimeters of internal circumference 
for all extravascular types. Therefore 
the vessel circumference must be 
accurately determined. One 
convenient method is to tie a suture 
around the vessel, cut the suture and 
measure its length with a millimeter 
scale. 
 
A given vessel will vary in size, 
sometimes greatly, between subjects 
of the same species and weight. It is 
suggested that measurements be made 
in a series of subjects to determine the 
normal range of vessel circumference. 
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Adult Human 
Vessel Sizes 
(Approximate Range in mm 
Circumference) 
 
Ascending Aorta . . . . . . . . . . 60-80 
Femoral . . . . . . . . . . . . . . . . . 15-20 
Iliac . . . . . . . . . . . . . . . . . . . . 25-35 
Vertebral . . . . . . . . . . . . . . . .   6-8 
Internal Carotid . . . . . . . . . . . 10-15 
Common Carotid . . . . . . . . . . 20-25 
Renal . . . . . . . . . . . . . . . . . . . 10-20 
Pulmonary Artery . . . . . . . . . 60-80 
Subclavian . . . . . . . . . . . . . .  15-20 
Saphenous Vein,  
Coronary Graft . . . . . . . . 12-20 
Saphenous Vein . . . . . . . . . . .  8-20 
Axillary Artery . . . . . . . . . . .  15-20 
Popliteal Artery . . . . . . . . . . . 12-20 
Posterior Tibial  . . . . . . . . . . .   6-10 
Abdominal Aorta . . . . . . . . . . 40-50 
Internal Mammary . . . . . . . . .  6-12 
Brachial . . . . . . . . . . . . . . . . . 15-20 
 
Calibration 
CLINIFLOW and CLINIFLOW 11 
probes are factory calibrated.  For 
maximum calibration accuracy, each 
probe must be calibrated by passing a 
measured quantity of saline through it 
and determining the relationship to 
flowmeter output. Once the calibration 
factor has been determined, it is a 
constant, and may be set into the 
flowmeter’s probe factor dial. This 
provides an output indication of flow 
directly in either milliliters or liters per 
minute. 
 
Sterilization 
DO NOT STEAM AUTOCLAVE. 
 
Sterilization is achieved by using 
ethylene oxide or standard germicidal 
solutions. Excessive or prolonged 
sterilization in germicidal solution may 
adversely affect a probe due to moisture 
absorption by the epoxy encapsulation.  
 
THE TEMPERATURE SHOULD 
NEVER EXCEED 65°C. 
 
Damaged probes should not be sterilized 
or used. 
 
 
 
 
 
 
 
 
Limited Warranty 
 A Limited Warranty is issued by Carolina 
Medical Electronics, Incorporated, and 
includes* the following terms: 
 
 1. This Warranty covers repair or 
replacement of parts of products 
manufactured by Carolina Medical 
Electronics which are defective in 
material or workmanship. Carolina 
Medical Electronics will pay for parts 
and labor only. 
 
2. The Warranty starts the date of 
shipment and lasts forgo days on the 
Plow Probes. 
 
3. CAROLINA MEDICAL 
ELECTRONICS MAKES NO OTHER 
EXPRESS WARRANTIES.  ANY 
IMPLIED WARRANTIES, 
INCLUDING WARRANTIES AS TO 
MERCHANTABILITY OR FITNESS 
FOR A PARTICULAR PURPOSE, 
ARE LIMITED IN DURATION TO 
THE PERIOD SET OUT IN 
PARAGRAPH 2 ABOVE. 
 
4. CAROLINA MEDICAL 
ELECTRONICS SHALL ITAVE NO 
RESPONSIBILITY FOR 
INCIDENTAL OR  ONSEQUENTIAL 
DAMAGES RESULTING FROM THE 
BREACH OF ANY WARRANTY, 
INCLUDING, BUT NOT LIMITED 
TO, INCONVENIENCE, RENTAL 
OR PURCHASE OF REPLACEMENT 
EQUIPMENT, LOSS OF PROFITS 
OR COMMERCIAL LOSS; SUBJECT 
TO THE LAWS OF YOUR STATE. 
 
5. This Warranty is not subject to change 
or modification by anyone, including 
Carolina Medical Electronics’ sales 
personnel and no such person is 
authorized to make any representations 
or promises on Carolina Medical 
Electronics’ behalf. 
 
*Refer to owner’s manual for complete 
provisions. Rights of design changes 
and circuit modifications are reserved. 
 
 
Other Conversions 
 
 
 
 
Circumference/ 
Diameter Conversion 
 
 
Metric Conversion 
 
 
French/Diameter 
Conversion 
 
 
 
 
 
 
 
 
French size divided by 3 = Diameter 
in mm. 
 
 
 
 
 
To 
Convert 
Inches 
Into 
Millimeters 
Multiply 
By 
25.40 
Millimeters Inches 0.03937 
Feet Meters 0.3048 
Meters Feet 3.28084 
Centimeters/Sec Meters/Sec 0.6 
CIR DIA  CIR DIA 
1 0.32  25 7.96 
2 0.64  30 9.55 
3 0.96  35 11.10 
4 1.27  40 12.73 
5 1.59  45 14.32 
6 1.91  50 15.92 
7 2.23  55 17.51 
8 2.55  60 19.10 
9 2.87  65 20.69 
10 3.18  70 22.28 
11 3.50  75 23.87 
12 3.82  80 25.46 
13 4.14  85 27.06 
14 4.46  90 28.65 
15 4.77  95 30.24 
16 5.09  100 31.83 
17 5.41  105 33.42 
18 5.73  110 35.01 
19 6.05  115 36.61 
20 6.37  120 38.20 
INCHES DECIMAL 
MILLI-
METERS 
1
/16 0.063 1.6 
1
/8 0.125 3.2 
1
/4 0.250 6.4 
3
/8 0.375 9.5 
1
/2 0.500 12.7 
NUMBER MILLI-METERS 
5 1.67 
6 2.0 
7 2.3 
8 2.7 
9 3.0 
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 Carolina Medical Electronics Probe Order Form 
 
 Model: EP-420-H-PV8-501    Series: EP-420-H-PV8-501 
 Code  Flowmeter     Code     Description 
   EP    FM501             1    Miniature Probe 
   EP    FM501D          2    Forceps Probe 
   SF    FM701D        3    Extracorporeal 
           4    Standard 
           6    IN VIVO 
  
 Size: EP-420-H-PV8-501    Options: EP-420-H-PV8-501 
 Series  Sizes (mm)     Increments (mm)         Code  Description 
   100       1 – 10     0.5     STD     Standard 
   200       6 – 20     2.0     H     Handle 
   200     20 – 125     5.0     R     Right Angle 
   300    1.6 – 12.7     3.2     S     Side Angle  
   400       4 – 20     2.0     BH     Bendable Handle 
   400     20 – 125     5.0     E     Eyelets 
   400-H      6 – 20     2.0     C     Chronic 
   400-H    20 – 35     5.0 
   600       4 – 20     2.0 
   600     20 – 125     5.0 
 
 
 Connector: EP-420-H-PV8-501   Flowmeter: EP-420-H-PV8-501 
 Code    Flowmeter     Code     Flowmeter 
 DB17    700 Series           501    FM501 
 PV8    500 Series         501D   FM501D 
 PSP8    Adaptor Needed      701D   FM701D 
 PVT    Adaptor Needed  
 
 
 Example Catalog #  _EP__ –  _420_ –  __H__ –  _PV8_ –  _501__ 
                Model     Series/Size       Options    Connector         Flowmeter 
   
      Order Catalog #  _____ –  ______ –  _____ –  _____ –  _______ 
                Model     Series/Size       Options    Connector         Flowmeter 
 
 Comments: _____________________________________________________ 
  
 ____________________________________________________________________________________ 
 
Note: Special sizes can be ordered but you must contact the factory first. 
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First in Flowmetry 
 
In 1955, Carolina Medical Electronics, Inc., developed the 
first commercial electromagnetic flowmeter, providing 
physicians and medical research scientists with an accurate and 
practical device for extravascular measurement of blood flow 
in surgically exposed but non-cannulated arteries and veins. 
It was a significant achievement, ranking in importance 
alongside the invention many years before of the 
sphygmomanometer, still used daily in hospitals and 
physicians’ offices for the measurement of human blood 
pressure. 
Until the development of the electromagnetic flowmeter, 
most of the knowledge of human blood circulation was based 
on pressure data. With the availability of an instrument to 
measure blood flow, the scope of cardiovascular research was 
broadened, leading to improved methods for evaluating 
circulatory problems and better patient management. 
The first electromagnetic transducer consisted basically of 
a small electromagnet encased in plastic and shaped in a 
fashion as to allow it to be slipped over and around a surgically 
exposed blood vessel. The vessel was positioned between the 
poles of the magnet, which was energized by electrical current 
to create a square-wave magnetic field. Voltage, generated 
bythe motion of the blood flowing through the magnetic field, 
was found to be proportional to the strength of the field, the 
velocity of the flow and the diameter of the vessel. 
This principle has not changed, but the instrumentation has 
been consistently improved to meet the changing needs of 
physicians and research scientists. 
CME’s principal interest has remained the continuous 
research, development and manufacture of the best, most 
reliable blood flowmeters available. Our experience in the field 
is unequaled. CME electromagnetic flowmeters are in use in 
hospitals and laboratories throughout the world. 
The CME Square-wave Electromagnetic Flowmeters 
measure volumetric blood flow in arteries and veins by 
intracorporeal and extravascular transducers. These 
instruments also are capable of measuring flows in 
extracorporeal systems such as pump oxygenators and 
perfusion equipment. 
The first blood flow measurements, both animal and 
human, using chronically implanted transducers, were made 
with CME flowmeters. CME research and development 
produced the intravascular catheter probe for blood velocity 
measurement patented). 
We are proud of our international reputation for quality 
instruments and quality service. Our foremost concern is that 
users of our instruments obtain the maximum performance 
which their equipment has been designed to provide. 
Overseas sales and service is provided through qualified 
technical representatives. 
 
COMPREHENSIVE BIBLIOGRAPHY ON BLOOD FLOW STUDIES 
USING ME FLOWMETERS IS AVAILABLE UPON REQUEST. 
 
Electromagnetic Blood Flowmeters 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Carolina Medical Electronics Inc 
4125 Old Mill Road, East Bend NC 27018 
www.carolinamedicalelectronics.com 
Phone: (336) 983-5132 Fax: (336) 699-3305 
ŀSquare-Wave Electromagnetic Blood Flowmeters CME 500 Series      
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Model 501 with multi-range analog panel meter 
Model 501D with digital readout 
This CME 500 Series is excellent for the critical 
requirements of research and laboratory applications. 
 
All models provide reliable operations in accurately 
measuring a wide spectrum of blood flow. A panel meter 
indicates a mean volumetric flow in milliliters per minute. 
 
These flowmeters have set the Standard of Excellence 
throughout the world for over thirty-five years. 
 
• Choice of panel meter or digital readout. 
• Provides non-occlusive zero flow reference. 
• Automatic protective circuits are designed to detect 
  system malfunction or deviation from normal 
  operating procedures. 
• Low noise – high resolution pulsatile flow data. 
• Adaptable for multiple flows by connecting to additional 
  units. 
• Extensive use of highly visible, lighted signal indicators. 
• Frequency response selectable up to 100Hz. 
• Separate recorder outputs provide mean and pulsatile 
  data simultaneously. 
• Industry’s widest range of precalibrated and 
  uncalibrated probes. 
 
 
RESEARCH ONLY 
 
 
 
SPECIFICATIONS 
ACCURACY 
Electrical Zero    Non-occlusive zero reference. 
Calibrate Signal -1.0V±5mV and 0.1V±2mV on mean and pulsatile outputs, toggle switch operated to calibrate external 
recorders and indicators. 
Flowmeter Calibration Accuracy ±5% after 30 minute warm-up. 
(Includes the effect to gain and excitation variation.) 
DC Drift    ±5% after 30 minute warm-up, cold start ±10mV. 
Linearity    ±1% maximum full scale. 
SAFETY 
Probe Leakage    Protection Probe current is removed if more than 200 µA leakage to ground occurs. 
(The CME Model 701D CLINIFLOW II is recommended for use on human subjects since its leakage is 
less than 20 µA.) 
INPUT CHARACTERISTICS 
Probe Excitation    500 Hz square-wave, 0.5 Ampere ±2%. Limited to ±15V open circuit. 50% duty cycle on 20mm and 
smaller probes. 
Amplifier Input    Differential 20MΩ plus 300ρf. Maximum input voltage 2V p-p. Common mode signals lower than 
350Hz produce an output 20dB below that produced by carrier reference. Signals in the range of 250Hz 
are approximately 40dB below carrier reference. 
OUTPUT CHARACTERISTICS 
Flow Range    5 milliliters/min to 19.99 liters/min depending on probe selected. 
Gain     Analog Model – 500K (at P.F. 500) .2µV p-p input produces 1.0VDC output, mean and pulsatile 
channels (Digital Model – 50K). 
Flow Indicator    Model 501D – Digital Readout. Model 501 – Panel Meter. Both calibrated in milliliters/min and liters/min. 
Outputs     Simultaneous mean and pulsatile single-ended analog outputs capable of ±5V swing. 
Normal full-scale mean output +1.0, -0.2VDC for analog model; ±1.999VDC for digital model. 
75Ω output impedance, short circuit protected. Minimum load impedance 1kΩ. 
Frequency Response   DC – 100Hz, ±3dB. 
Output Noise    50mV typical (0.1µV RMS referenced to shortened input @ 25K overall gain). 
GENERAL 
Power Requirements   115V±10V, 50-60Hz, (501, 40 Watts) (501D, 42 Watts). Optional 100VAC, 230VAC. 
Operating Temperature   15ºC to 27ºC (60ºF to 80ºF) Ambient 
Size & Weight    21 x 21 x 28 cm HWD (8.25 x 8.25 x 11 in. HWD). 
5.5kg (12 lbs.). 
Colors     Burgundy with gray trim. 
Specifications subject to change without notice. 
 
LIMITED WARRANTY 
The CME 500 Series is only sold subject to the terms of a 
Limited Warranty. This Limited Warranty contains important 
provisions restricting and limiting the seller’s responsibilities 
and liabilities.  The Limited warranty in its entirety appears 
within the preface of the Operation and Maintenance 
Instruction Manual. The Limited Warranty may also be 
obtained from our sales representatives or at our home office. 
 
Carolina Medical Electronics 
 “Diagnostic Instruments for Quality Health Care” 
4125 Old Mill Road 
East Bend, NC 27018 USA 
(336) 983-5132  Fax: (336) 699-3305 
www.carolinamedicalelectronics.com
 
Appendix C MATLAB Codes
C.1 Uncertainty in Pressure
clear
clc
close all
datm1=load('0603PerfectValve1.txt');
datm2=load('0603PerfectValve2.txt');
datm3=load('0603PerfectValve3.txt');
datm4=load('0603PerfectValve4.txt');
datm5=load('0603PerfectValve5.txt');
dat01=load('0603NoValve1.txt');
dat02=load('0603NoValve2.txt');
dat03=load('0603NoValve3.txt');
dat04=load('0603NoValve4.txt');
datR2=load('0603Resistance2.txt');
datR3=load('0603Resistance3.txt');
datR4=load('0603Resistance4.txt');
datR5=load('0603Resistance5.txt');
datB1=load('0603BiologicalValve1.txt');
datB3=load('0603BiologicalValve3.txt');
datB4=load('0603BiologicalValve4.txt');
datB5=load('0603BiologicalValve5.txt');
%P1m1=datm1(:,4);
%P10=dat0(:,4);
%P1R=datR(:,4);
%P1B=datB(:,4);
%% u_1
P=[datm1(1:400,4);datm1(15000:16000,4);datm2(1:400,4);datm2...
(15000:16000,4);datm3(1:400,4);datm3(15000:16000,4);datm4...
(1:400,4);datm4(15000:16000,4);datm5(1:400,4);datm5...
(15000:16000,4);dat01(1:400,4);dat01(15000:16000,4);dat02...
(1:400,4);dat02(15000:16000,4);dat03(1:400,4);dat03...
(15000:16000,4);dat04(1:400,4);dat04(15000:16000,4);datR2...
(1:400,4);datR2(15000:16000,4);datR3(1:400,4);datR3...
(15000:16000,4);datR4(1:400,4);datR4(15000:16000,4);datR5...
(1:400,4);datR5(15000:16000,4);datB1(1:400,4);datB1...
(15000:16000,4);datB3(1:400,4);datB3(15000:16000,4);datB4...
(1:400,4);datB4(15000:16000,4);datB5(1:400,4);datB5...
(15000:16000,4)];
%P=datm1(1:400,4);
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M=mean(P);
S=std(P);
Sx=S/sqrt(length(P));
t=tinv(0.975,length(P)-1);
u0=0.005;
u1=t*Sx;
usp=sqrt(.2ˆ2+.147ˆ2);
u=sqrt(u0ˆ2+u1ˆ2+uspˆ2);
C.2 Resistance Calculation
C.2.1 Resistance.m
%% Resistanc
clear
clc
close all
%% Load Data
dat0=load('0603NoValveTestSectionR.txt');
datm=load('0603Rm3.txt');
datBfor=load('0603RForward2.txt');
datBback=load('0603Rbacki2.txt');
datR=load('0603ResistanceTestSectionR.txt');
datFemIVC=load('0603Rivcandfem3.txt');
datsve=load('0603Rsve2.txt');
datvn=load('0603VenuleNotCrossValveR1.txt');
datFem=datFemIVC;
datIVC=datFemIVC;
datIVC(:,5)=datFemIVC(:,4);
datIVC(:,4)=88.12;
tol=0.5;
up=0.25;
uq=0.026;
%% Use Rfun to find Resistances where Applicable
[t0,P10,P20,Q0,R0,Ri0,Rmean0,Rstd0,ur0]=Rfun(dat0,tol,up,uq);
[tm,P1m,P2m,Qm,Rm,Rim,Rmeanm,Rstdm,urm]=Rfun(datm,tol,up,uq);
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[tBfor,P1Bfor,P2Bfor,QBfor,RBfor,RiBfor,RmeanBfor,RstdBfor,urBfor]=...
Rfun(datBfor,tol,up,uq);
[tBback,P1Bback,P2Bback,QBback,RBback,RiBback,RmeanBback,RstdBback,...
urBback]=Rfun(datBback,tol,up,uq);
[tR,P1R,P2R,QR,RR,RiR,RmeanR,RstdR,urR]=Rfun(datR,tol,up,uq);
[tFem,P1Fem,P2Fem,QFem,RFem,RiFem,RmeanFem,RstdFem,urFem]=Rfun(datFem...
,tol,up,uq);
[tIVC,P1IVC,P2IVC,QIVC,RIVC,RiIVC,RmeanIVC,RstdIVC,urIVC]=Rfun(datIVC...
,tol,up,uq);
[tsve,P1sve,P2sve,Qsve,Rsve,Risve,Rmeansve,Rstdsve,ursve]=Rfun(datsve...
,tol,up,uq);
[tvn,P1vn,P2vn,Qvn,Rvn,Rivn,Rmeanvn,Rstdvn,urvn]=Rfun(datvn,tol,up,uq...
);
C.2.2 Rfun.m
function[t,P1,P2,Q,R,Ri,Rmean,Rstd,ur]=Rfun(dat,tol,up,uq)
t(:,1)=dat(:,1)-dat(1,1);
P1(:,1)=dat(:,4);
P2(:,1)=dat(:,5);
Q(:,1)=dat(:,2);
count1=1;
count2=1;
Q=Q*1000/60;
Q(:)=Q(:)-Q(1);
for i=1:length(P1)
Ri(i,1)=abs((P1(i)-P2(i))/(Q(i)));
if abs(Q(i))>tol
if Ri(i,1)>0
R(count2,1)=Ri(i,1);
Rqu(count2,1)=abs((P1(i)-P2(i))/(Q(i))+uq);
Rqd(count2,1)=abs((P1(i)-P2(i))/(Q(i))-uq);
Rpu(count2,1)=abs((P1(i)-P2(i)+up)/(Q(i)));
Rpd(count2,1)=abs((P1(i)-P2(i)-up)/(Q(i)));
count2=count2+1;
end
end
end
Rmean=mean(R);
Rstd=std(R);
Rqumean=mean(Rqu);
Rqdmean=mean(Rqd);
Rpumean=mean(Rpu);
Rpdmean=mean(Rpd);
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ur=sqrt(((Rqumean-Rqdmean)/2)ˆ2+((Rpumean-Rpdmean)/2)ˆ2);
end
C.3 Compliance Calculation
%%
clear
clc
close all
up=0.25;
uh=0.05;
%% Calculate Compliances
Csve=pi*((10.16)/2)ˆ2*(6.9)/(88.12+760);
Csveu1=pi*((10.16+uh)/2)ˆ2*(6.9)/(88.12+760);
Csved1=pi*((10.16-uh)/2)ˆ2*(6.9)/(88.12+760);
Csveu2=pi*((10.16)/2)ˆ2*(6.9+uh)/(88.12+760);
Csved2=pi*((10.16)/2)ˆ2*(6.9-uh)/(88.12+760);
Csveu3=pi*((10.16)/2)ˆ2*(6.9)/(88.12+up+760);
Csved3=pi*((10.16)/2)ˆ2*(6.9)/(88.12-up+760);
ucsve=sqrt(((Csveu1-Csved1)/2)ˆ2+((Csveu2-Csved2)/2)ˆ2+((Csveu3-...
Csved3)/2)ˆ2);
Cfem=pi*((10.16)/2)ˆ2*(20)/(88.12+760);
Cfemu1=pi*((10.16+uh)/2)ˆ2*(20)/(88.12+760);
Cfemd1=pi*((10.16-uh)/2)ˆ2*(20)/(88.12+760);
Cfemu2=pi*((10.16)/2)ˆ2*(20+uh)/(88.12+760);
Cfemd2=pi*((10.16)/2)ˆ2*(20-uh)/(88.12+760);
Cfemu3=pi*((10.16)/2)ˆ2*(20)/(88.12+up+760);
Cfemd3=pi*((10.16)/2)ˆ2*(20)/(88.12-up+760);
ucfem=sqrt(((Cfemu1-Cfemd1)/2)ˆ2+((Cfemu2-Cfemd2)/2)ˆ2+((Cfemu3-...
Cfemd3)/2)ˆ2);
Csveg=pi*((3/8)/2*0.0254)ˆ2/(1000*9.81)*1.333*10ˆ8;
Csvegu1=pi*((3/8+uh/2.54)/2*0.0254)ˆ2/(1000*9.81)*1.333*10ˆ8;
Csvegd1=pi*((3/8-uh/2.54)/2*0.0254)ˆ2/(1000*9.81)*1.333*10ˆ8;
ucsveg=abs((Csvegu1-Csvegd1)/2);
Cmp=pi*((0.9525)/2)ˆ2*(55.8)/(215.6);
Cmpu1=pi*((0.9525+uh)/2)ˆ2*(55.8)/(215.6);
Cmpd1=pi*((0.9525-uh)/2)ˆ2*(55.8)/(215.6);
Cmpu2=pi*((0.9525)/2)ˆ2*(55.8+uh)/(215.6);
Cmpd2=pi*((0.9525)/2)ˆ2*(55.8-uh)/(215.6);
Cmpu3=pi*((0.9525)/2)ˆ2*(55.8)/(215.6+up);
Cmpd3=pi*((0.9525)/2)ˆ2*(55.8)/(215.6-up);
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ucmp=sqrt(((Cmpu1-Cmpd1)/2)ˆ2+((Cmpu2-Cmpd2)/2)ˆ2+((Cmpu3-Cmpd3)/2)...
ˆ2);
C.4 Pressure and Flow Calculation
C.4.1 MockVeinSystem.m
%% Initialize
clear
clc
close all
%% Load Data
datm=load('0603PerfectValve2.txt');
dat0=load('0603NoValve2.txt');
datR=load('0603Resistance2.txt');
datB=load('0603BiologicalValve4.txt');
period=1;
SPS=80;
MaxTime=200;
Delay=5;
OnCycles=100;
up=0.25;
ul=0.5;
upl=sqrt(upˆ2+ulˆ2);
uq=0.026;
POC=Delay+OnCycles;
DP=Delay*SPS+1;
Off=POC*SPS;
I=Off+1;
set(0,'DefaultAxesFontSize',20);
%% Parse Data
[tm,P1m,P2m,Qm,tmAvg,P1mAvg,P2mAvg]=parse(datm,period,SPS);
[t0,P10,P20,Q0,t0Avg,P10Avg,P20Avg]=parse(dat0,period,SPS);
[tR,P1R,P2R,QR,tRAvg,P1RAvg,P2RAvg]=parse(datR,period,SPS);
[tB,P1B,P2B,QB,tBAvg,P1BAvg,P2BAvg]=parse(datB,period,SPS);
Qm(:)=Qm(:)-Qm(1);
Q0(:)=Q0(:)-Q0(1);
QR(:)=QR(:)-QR(1);
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QB(:)=QB(:)-QB(1);
%% filtfilt Data
P1mI=P1m-P1m(1);
P10I=P10-P10(1);
P1RI=P1R-P1R(1);
P1BI=P1B-P1B(1);
fs=80; % Sample Freuency
fn=fs/2; % Nyquist Frequency
fc=1.5; % Desired Cutoff frequency (example)
[b,a]=butter(2,fc/fn); % IIR filtfilt coefficients, b=num, a=denom
P1mF=filtfilt(b,a,P1mI)+P1m(1);
P10F=filtfilt(b,a,P10I)+P10(1);
P1RF=filtfilt(b,a,P1RI)+P1R(1);
P1BF=filtfilt(b,a,P1BI)+P1B(1);
P1mN=P1mF/P1mF(1);
P10N=P10F/P10F(1);
P1RN=P1RF/P1RF(1);
P1BN=P1BF/P1BF(1);
%}
%% Recovery
tmR=tm(I:length(tm),1);
t0R=t0(I:length(t0),1);
tRR=tR(I:length(tR),1);
tBR=tB(I:length(tB),1);
tmR=tmR-tmR(1);
t0R=t0R-t0R(1);
tRR=tRR-tRR(1);
tBR=tBR-tBR(1);
P1mR=P1mF(I:length(P1mF),1);
P10R=P10F(I:length(P10F),1);
P1RR=P1RF(I:length(P1RF),1);
P1BR=P1BF(I:length(P1BF),1);
P1mRN=P1mR/P1mR(length(P1mR));
P10RN=P10R/P10R(length(P10R));
P1RRN=P1RR/P1RR(length(P1RR));
P1BRN=P1BR/P1BR(length(P1BR));
%% During Pumping
tmD=tm(DP:Off,1);
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t0D=t0(DP:Off,1);
tRD=tR(DP:Off,1);
tBD=tB(DP:Off,1);
tmD=tmD-tmD(1);
t0D=t0D-t0D(1);
tRD=tRD-tRD(1);
tBD=tBD-tBD(1);
P1mD=P1mF(DP:Off,1);
P10D=P10F(DP:Off,1);
P1RD=P1RF(DP:Off,1);
P1BD=P1BF(DP:Off,1);
P1mDN=P1mD/P1mD(1);
P10DN=P10D/P10D(1);
P1RDN=P1RD/P1RD(1);
P1BDN=P1BD/P1BD(1);
P1mRNu=P1mRN+upl/P1mR(length(P1mR));
P1mRNd=P1mRN-upl/P1mR(length(P1mR));
P10RNu=P10RN+upl/P10R(length(P10R));
P10RNd=P10RN-upl/P10R(length(P10R));
P1RRNu=P1RRN+upl/P1RR(length(P1RR));
P1RRNd=P1RRN-upl/P1RR(length(P1RR));
P1BRNu=P1BRN+upl/P1BR(length(P1BR));
P1BRNd=P1BRN-upl/P1BR(length(P1BR));
%% Plot
Multi=figure;
hold on
plot(tR,P1RF,'color',[0.75,0.75,0.75],'LineWidth',1);
plot(t0,P10F,'color',[0,0,0],'LineWidth',2);
plot(tB,P1BF,'color',[0.75,0.75,0.75],'LineWidth',2);
plot(tm,P1mF,'color',[0,0,0],'LineWidth',1);
hold off
%title('Pressure');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,200,0,150]);
legend('Thrombosis','No Valve','Biological Valve','Gate Valve');
saveas(Multi, 'C:\Users\Ross\Documents\Research Related\Thesis\Inputs...
\Pictures\Multi.png','png');
MultiN=figure;
hold on
plot(tR,P1RN,'color',[0.75,0.75,0.75],'LineWidth',1);
plot(t0,P10N,'color',[0,0,0],'LineWidth',2);
plot(tB,P1BN,'color',[0.75,0.75,0.75],'LineWidth',2);
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plot(tm,P1mN,'color',[0,0,0],'LineWidth',1);
hold off
%title('Normalized Pressure');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,200,0,1.5]);
legend('Thrombosis','No Valve','Biological Valve','Gate Valve');
saveas(MultiN,'C:\Users\Ross\Documents\Research Related\Thesis\Inputs...
\Pictures\MultiN.png','png');
MultiR=figure;
hold on
plot(tRR,P1RR,'color',[0.75,0.75,0.75],'LineWidth',1);
plot(t0R,P10R,'color',[0,0,0],'LineWidth',2);
plot(tBR,P1BR,'color',[0.75,0.75,0.75],'LineWidth',2);
plot(tmR,P1mR,'color',[0,0,0],'LineWidth',1);
hold off
%title('Pressure During Recover');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,95,0,150]);
legend('Thrombosis','No Valve','Biological Valve','Gate Valve');
saveas(MultiR,'C:\Users\Ross\Documents\Research Related\Thesis\Inputs...
\Pictures\MultiR.png','png');
MultiRN=figure;
hold on
plot(tRR,P1RRN,'color',[0.75,0.75,0.75],'LineWidth',1);
plot(t0R,P10RN,'color',[0,0,0],'LineWidth',2);
plot(tBR,P1BRN,'color',[0.75,0.75,0.75],'LineWidth',2);
plot(tmR,P1mRN,'color',[0,0,0],'LineWidth',1);
hold off
%title('Normalized Pressure During Recover');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,95,0,1.5]);
legend('Thrombosis','No Valve','Biological Valve','Gate Valve');
saveas(MultiRN,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\MultiRN.png','png');
MultiD=figure;
hold on
plot(tRD,P1RD,'color',[0.75,0.75,0.75],'LineWidth',1);
plot(t0D,P10D,'color',[0,0,0],'LineWidth',2);
plot(tBD,P1BD,'color',[0.75,0.75,0.75],'LineWidth',2);
plot(tmD,P1mD,'color',[0,0,0],'LineWidth',1);
hold off
%title('Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
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axis([0,100,0,150]);
legend('Thrombosis','No Valve','Biological Valve','Gate Valve');
saveas(MultiD,'C:\Users\Ross\Documents\Research Related\Thesis\Inputs...
\Pictures\MultiD.png','png');
MultiDN=figure;
hold on
plot(tRD,P1RDN,'color',[0.75,0.75,0.75],'LineWidth',1);
plot(t0D,P10DN,'color',[0,0,0],'LineWidth',2);
plot(tBD,P1BDN,'color',[0.75,0.75,0.75],'LineWidth',2);
plot(tmD,P1mDN,'color',[0,0,0],'LineWidth',1);
hold off
%title('Normalized Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,100,0,1.5]);
legend('Thrombosis','No Valve','Biological Valve','Gate Valve');
saveas(MultiDN,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\MultiDN.png','png');
%%
% No Valve
NoValve=figure;
plot(t0,P10F,'black');
%title('Pressure');
axis([0,200,0,150]);
ah = gca;
s_pos =[80 40 85 100];
t_pos = [90 100 120 140];
zoomPlot(ah, s_pos, t_pos);
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
saveas(NoValve, 'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\NoValve.png','png');
NoValveN=figure;
plot(t0,P10N,'black');
%title('Normalized Pressure');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,200,0,1.5]);
saveas(NoValveN,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\NoValveN.png','png');
NoValveR=figure;
plot(t0R,P10R,'black')
%title('Pressure During Recover');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
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axis([0,95,0,150]);
saveas(NoValveR,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\NoValveR.png','png');
NoValveRN=figure;
plot(t0R,P10RN,'black')
%title('Normalized Pressure During Recover');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,95,0,1.5]);
saveas(NoValveRN,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\NoValveRN.png','png');
NoValveD=figure;
plot(t0D,P10D,'black')
%title('Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,100,0,150]);
saveas(NoValveD,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\NoValveD.png','png');
NoValveDN=figure;
plot(t0D,P10DN,'black')
%title('Normalized Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,100,0,1.5]);
saveas(NoValveDN,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\NoValveDN.png','png');
% Perfect Valve
PerfectValve=figure;
plot(tm,P1mF,'black');
%title('Pressure');
axis([0,200,0,150]);
ah = gca;
s_pos =[80 3 85 10];
t_pos = [70 30 100 70];
zoomPlot(ah,s_pos,t_pos);
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
saveas(PerfectValve, 'C:\Users\Ross\Documents\Research Related\Thesis...
\Inputs\Pictures\PerfectValve.png','png');
PerfectValveN=figure;
plot(tm,P1mN,'black');
%title('Normalized Pressure');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,200,0,1.5]);
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saveas(PerfectValveN,'C:\Users\Ross\Documents\Research Related\Thesis...
\Inputs\Pictures\PerfectValveN.png','png');
PerfectValveR=figure;
plot(tmR,P1mR,'black')
%title('Pressure During Recover');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,95,0,150]);
saveas(PerfectValveR,'C:\Users\Ross\Documents\Research Related\Thesis...
\Inputs\Pictures\PerfectValveR.png','png');
PerfectValveRN=figure;
plot(tmR,P1mRN,'black')
%title('Normalized Pressure During Recover');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,95,0,1.5]);
saveas(PerfectValveRN,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\PerfectValveRN.png','png');
PerfectValveD=figure;
plot(tmD,P1mD,'black')
%title('Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,100,0,150]);
saveas(PerfectValveD,'C:\Users\Ross\Documents\Research Related\Thesis...
\Inputs\Pictures\PerfectValveD.png','png');
PerfectValveDN=figure;
plot(tmD,P1mDN,'black')
%title('Normalized Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,100,0,1.5]);
saveas(PerfectValveDN,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\PerfectValveDN.png','png');
% Biological Valve
BiologicalValve=figure;
plot(tB,P1BF,'black');
%title('Pressure');
axis([0,200,0,150]);
ah = gca;
s_pos =[80 12 85 29];
t_pos = [70 40 100 80];
zoomPlot(ah, s_pos, t_pos);
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
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saveas(BiologicalValve, 'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\BiologicalValve.png','png');
BiologicalValveN=figure;
plot(tB,P1BN,'black');
%title('Normalized Pressure');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,200,0,1.5]);
saveas(BiologicalValveN,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\BiologicalValveN.png','png');
BiologicalValveR=figure;
plot(tBR,P1BR,'black')
%title('Pressure During Recover');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,95,0,150]);
saveas(BiologicalValveR,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\BiologicalValveR.png','png');
BiologicalValveRN=figure;
plot(tBR,P1BRN,'black')
%title('Normalized Pressure During Recover');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,95,0,1.5]);
saveas(BiologicalValveRN,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\BiologicalValveRN.png','png');
BiologicalValveD=figure;
plot(tBD,P1BD,'black')
%title('Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,100,0,150]);
saveas(BiologicalValveD,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\BiologicalValveD.png','png');
BiologicalValveDN=figure;
plot(tBD,P1BDN,'black')
%title('Normalized Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,100,0,1.5]);
saveas(BiologicalValveDN,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\BiologicalValveDN.png','png');
% Thrombosis
Thrombosis=figure;
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plot(tR,P1RF,'black');
%title('Pressure');
axis([0,200,0,150]);
ah = gca;
s_pos =[80 63 85 138];
t_pos = [90 10 110 50];
zoomPlot(ah,s_pos,t_pos);
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
saveas(Thrombosis, 'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\Thrombosis.png','png');
ThrombosisN=figure;
plot(tR,P1RN,'black');
%title('Normalized Pressure');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,200,0,1.5]);
saveas(ThrombosisN,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\ThrombosisN.png','png');
ThrombosisR=figure;
plot(tRR,P1RR,'black')
%title('Pressure During Recover');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,95,0,150]);
saveas(ThrombosisR,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\ThrombosisR.png','png');
ThrombosisRN=figure;
plot(tRR,P1RRN,'black')
%title('Normalized Pressure During Recover');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,95,0,1.5]);
saveas(ThrombosisRN,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\ThrombosisRN.png','png');
ThrombosisD=figure;
plot(tRD,P1RD,'black')
%title('Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,100,0,150]);
saveas(ThrombosisD,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\ThrombosisD.png','png');
ThrombosisDN=figure;
plot(tRD,P1RDN,'black')
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%title('Normalized Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,100,0,1.5]);
saveas(ThrombosisDN,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\ThrombosisDN.png','png');
%}
%% Average
P10AvgN=P10Avg/P10Avg(1);
P1mAvgN=P1mAvg/P1mAvg(1);
P1BAvgN=P1BAvg/P1BAvg(1);
P1RAvgN=P1RAvg/P1RAvg(1);
t0AvgR=t0Avg(POC+1:length(t0Avg));
tmAvgR=tmAvg(POC+1:length(tmAvg));
tBAvgR=tBAvg(POC+1:length(tBAvg));
tRAvgR=tRAvg(POC+1:length(tRAvg));
t0AvgR=t0AvgR-t0AvgR(1);
tmAvgR=tmAvgR-tmAvgR(1);
tBAvgR=tBAvgR-tBAvgR(1);
tRAvgR=tRAvgR-tRAvgR(1);
P10AvgR=P10Avg(POC+1:length(P10Avg));
P1mAvgR=P1mAvg(POC+1:length(P1mAvg));
P1BAvgR=P1BAvg(POC+1:length(P1BAvg));
P1RAvgR=P1RAvg(POC+1:length(P1RAvg));
P10AvgRN=P10AvgR/P10AvgR(length(P10AvgR));
P1mAvgRN=P1mAvgR/P1mAvgR(length(P1mAvgR));
P1BAvgRN=P1BAvgR/P1BAvgR(length(P1BAvgR));
P1RAvgRN=P1RAvgR/P1RAvgR(length(P1RAvgR));
t0AvgD=t0Avg(Delay+1:POC);
tmAvgD=tmAvg(Delay+1:POC);
tBAvgD=tBAvg(Delay+1:POC);
tRAvgD=tRAvg(Delay+1:POC);
t0AvgD=t0AvgD-t0AvgD(1);
tmAvgD=tmAvgD-tmAvgD(1);
tBAvgD=tBAvgD-tBAvgD(1);
tRAvgD=tRAvgD-tRAvgD(1);
P10AvgD=P10Avg(Delay+1:POC);
P1mAvgD=P1mAvg(Delay+1:POC);
P1BAvgD=P1BAvg(Delay+1:POC);
P1RAvgD=P1RAvg(Delay+1:POC);
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P10AvgDN=P10AvgD/P10AvgD(1);
P1mAvgDN=P1mAvgD/P1mAvgD(1);
P1BAvgDN=P1BAvgD/P1BAvgD(1);
P1RAvgDN=P1RAvgD/P1RAvgD(1);
MultiAvg=figure;
hold on
plot(tRAvg,P1RAvg,'color',[0.75,0.75,0.75],'LineWidth',1);
plot(t0Avg,P10Avg,'color',[0,0,0],'LineWidth',2);
plot(tBAvg,P1BAvg,'color',[0.75,0.75,0.75],'LineWidth',2);
plot(tmAvg,P1mAvg,'color',[0,0,0],'LineWidth',1);
hold off
%title('Pressure');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,200,0,150]);
legend('Thrombosis','No Valve','Biological Valve','Gate Valve');
saveas(MultiAvg, 'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\MultiAvg.png','png');
MultiAvgN=figure;
hold on
plot(tRAvg,P1RAvgN,'color',[0.75,0.75,0.75],'LineWidth',1);
plot(t0Avg,P10AvgN,'color',[0,0,0],'LineWidth',2);
plot(tBAvg,P1BAvgN,'color',[0.75,0.75,0.75],'LineWidth',2);
plot(tmAvg,P1mAvgN,'color',[0,0,0],'LineWidth',1);
hold off
%title('Normalized Pressure');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,200,0,1.5]);
legend('Thrombosis','No Valve','Biological Valve','Gate Valve');
saveas(MultiAvgN,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\MultiAvgN.png','png');
MultiAvgR=figure;
hold on
plot(tRAvgR,P1RAvgR,'color',[0.75,0.75,0.75],'LineWidth',1);
plot(t0AvgR,P10AvgR,'color',[0,0,0],'LineWidth',2);
plot(tBAvgR,P1BAvgR,'color',[0.75,0.75,0.75],'LineWidth',2);
plot(tmAvgR,P1mAvgR,'color',[0,0,0],'LineWidth',1);
hold off
%title('Pressure During Re0DN,cover');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,95,0,150]);
legend('Thrombosis','No Valve','Biological Valve','Gate Valve');
saveas(MultiAvgR,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\MultiAvgR.png','png');
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MultiAvgRN=figure;
plot(t0AvgR,P10AvgRN,'red',tmAvgR,P10AvgRN,'blue',tBAvgR,P1BAvgRN,'...
black',tRAvgR,P1RAvgRN,'black');
hold on
plot(tRAvgR,P1RAvgRN,'color',[0.75,0.75,0.75],'LineWidth',1);
plot(t0AvgR,P10AvgRN,'color',[0,0,0],'LineWidth',2);
plot(tBAvgR,P1BAvgRN,'color',[0.75,0.75,0.75],'LineWidth',2);
plot(tmAvgR,P1mAvgRN,'color',[0,0,0],'LineWidth',1);
hold off
%title('Normalized Pressure During Recover');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,95,0,1.5]);
legend('Thrombosis','No Valve','Biological Valve','Gate Valve');
saveas(MultiAvgRN,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\MultiAvgRN.png','png');
MultiAvgD=figure;
hold on
plot(tRAvgD,P1RAvgD,'color',[0.75,0.75,0.75],'LineWidth',1);
plot(t0AvgD,P10AvgD,'color',[0,0,0],'LineWidth',2);
plot(tBAvgD,P1BAvgD,'color',[0.75,0.75,0.75],'LineWidth',2);
plot(tmAvgD,P1mAvgD,'color',[0,0,0],'LineWidth',1);
hold off
%title('Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,100,0,150]);
legend('Thrombosis','No Valve','Biological Valve','Gate Valve');
saveas(MultiAvgD,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\MultiAvgD.png','png');
MultiAvgDN=figure;
hold on
plot(tRAvgD,P1RAvgDN,'color',[0.75,0.75,0.75],'LineWidth',1);
plot(t0AvgD,P10AvgDN,'color',[0,0,0],'LineWidth',2);
plot(tBAvgD,P1BAvgDN,'color',[0.75,0.75,0.75],'LineWidth',2);
plot(tmAvgD,P1mAvgDN,'color',[0,0,0],'LineWidth',1);
hold off
%title('Normalized Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,100,0,1.5]);
legend('Thrombosis','No Valve','Biological Valve','Gate Valve');
saveas(MultiAvgDN,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\MultiAvgDN.png','png');
%%
% No Valve
NoValveAvg=figure;
125
plot(t0Avg,P10Avg,'black');
%title('Pressure');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,200,0,150]);
saveas(NoValveAvg, 'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\NoValveAvg.png','png');
NoValveAvgN=figure;
plot(t0Avg,P10AvgN,'black');
%title('Normalized Pressure');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,200,0,1.5]);
saveas(NoValveAvgN,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\NoValveAvgN.png','png');
NoValveAvgR=figure;
plot(t0AvgR,P10AvgR,'black')
%title('Pressure During Recover');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,95,0,150]);
saveas(NoValveAvgR,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\NoValveAvgR.png','png');
NoValveAvgRN=figure;
plot(t0AvgR,P10AvgRN,'black')
%title('Normalized Pressure During Recover');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,95,0,1.5]);
saveas(NoValveAvgRN,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\NoValveAvgRN.png','png');
NoValveAvgD=figure;
plot(t0AvgD,P10AvgD,'black')
%title('Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,100,0,150]);
saveas(NoValveAvgD,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\NoValveAvgD.png','png');
NoValveAvgDN=figure;
plot(t0AvgD,P10AvgDN,'black')
%title('Normalized Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,100,0,1.5]);
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saveas(NoValveAvgDN,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\NoValveAvgDN.png','png');
% Perfect Valve
PerfectValveAvg=figure;
plot(tmAvg,P1mAvg,'black');
%title('Pressure');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,200,0,150]);
saveas(PerfectValveAvg, 'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\PerfectValveAvg.png','png');
PerfectValveAvgN=figure;
plot(tmAvg,P1mAvgN,'black');
%title('Normalized Pressure');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,200,0,1.5]);
saveas(PerfectValveAvgN,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\PerfectValveAvgN.png','png');
PerfectValveAvgR=figure;
plot(tmAvgR,P1mAvgR,'black')
%title('Pressure During Recover');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,95,0,150]);
saveas(PerfectValveAvgR,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\PerfectValveAvgR.png','png');
PerfectValveAvgRN=figure;
plot(tmAvgR,P10AvgRN,'black')
%title('Normalized Pressure During Recover');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,95,0,1.5]);
saveas(PerfectValveAvgRN,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\PerfectValveAvgRN.png','png');
PerfectValveAvgD=figure;
plot(tmAvgD,P1mAvgD,'black')
%title('Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,100,0,150]);
saveas(PerfectValveAvgD,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\PerfectValveAvgD.png','png');
PerfectValveAvgDN=figure;
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plot(tmAvgD,P1mAvgDN,'black')
%title('Normalized Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,100,0,1.5]);
saveas(PerfectValveAvgDN,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\PerfectValveAvgDN.png','png');
% Biological Valve
BiologicalValveAvg=figure;
plot(tBAvg,P1BAvg,'black');
%title('Pressure');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,200,0,150]);
saveas(BiologicalValveAvg, 'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\BiologicalValveAvg.png','png');
BiologicalValveAvgN=figure;
plot(tBAvg,P1BAvgN,'black');
%title('Normalized Pressure');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,200,0,1.5]);
saveas(BiologicalValveAvgN,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\BiologicalValveAvgN.png','png');
BiologicalValveAvgR=figure;
plot(tBAvgR,P1BAvgR,'black')
%title('Pressure During Recover');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,95,0,150]);
saveas(BiologicalValveAvgR,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\BiologicalValveAvgR.png','png');
BiologicalValveAvgRN=figure;
plot(tBAvgR,P1BAvgRN,'black')
%title('Normalized Pressure During Recover');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,95,0,1.5]);
saveas(BiologicalValveAvgRN,'C:\Users\Ross\Documents\Research Related...
\Thesis\Inputs\Pictures\BiologicalValveAvgRN.png','png');
BiologicalValveAvgD=figure;
plot(tBAvgD,P1BAvgD,'black')
%title('Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
128
axis([0,100,0,150]);
saveas(BiologicalValveAvgD,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\BiologicalValveAvgD.png','png');
BiologicalValveAvgDN=figure;
plot(tBAvgD,P1BAvgDN,'black')
%title('Normalized Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,100,0,1.5]);
saveas(BiologicalValveAvgDN,'C:\Users\Ross\Documents\Research Related...
\Thesis\Inputs\Pictures\BiologicalValveAvgDN.png','png');
% ThrombosisAvg
ThrombosisAvg=figure;
plot(tRAvg,P1RAvg,'black');
%title('Pressure');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,200,0,150]);
saveas(ThrombosisAvg, 'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\ThrombosisAvg.png','png');
ThrombosisAvgN=figure;
plot(tRAvg,P1RAvgN,'black');
%title('Normalized Pressure');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,200,0,1.5]);
saveas(ThrombosisAvgN,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\ThrombosisAvgN.png','png');
ThrombosisAvgR=figure;
plot(tRAvgR,P1RAvgR,'black')
%title('Pressure During Recover');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,95,0,150]);
saveas(ThrombosisAvgR,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\ThrombosisAvgR.png','png');
ThrombosisAvgRN=figure;
plot(tRAvgR,P1RAvgRN,'black')
%title('Normalized Pressure During Recover');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,95,0,1.5]);
saveas(ThrombosisAvgRN,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\ThrombosisAvgRN.png','png');
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ThrombosisAvgD=figure;
plot(tRAvgD,P1RAvgD,'black')
%title('Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,100,0,150]);
saveas(ThrombosisAvgD,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\ThrombosisAvgD.png','png');
ThrombosisAvgDN=figure;
plot(tRAvgD,P1RAvgDN,'black')
%title('Normalized Pressure During Muscle Pump');
xlabel('Time [s]');
ylabel('Normalized Pressure');
axis([0,100,0,1.5]);
saveas(ThrombosisAvgDN,'C:\Users\Ross\Documents\Research Related\...
Thesis\Inputs\Pictures\ThrombosisAvgDN.png','png');
%}
%% Q
QmI=Qm-Qm(1);
Q0I=Q0-Q0(1);
QRI=QR-QR(1);
QBI=QB-QB(1);
fsF=80; % Sample Freuency
fnF=fsF/2; % Nyquist Frequency
fcF=1.2; % Desired Cutoff frequency (example)
[bF,aF]=butter(2,fcF/fnF); % IIR filtfilt coefficients, b=num, a=...
denom
QmF=filtfilt(bF,aF,QmI)+Qm(1);
Q0F=filtfilt(bF,aF,Q0I)+Q0(1);
QRF=filtfilt(bF,aF,QRI)+QR(1);
QBF=filtfilt(bF,aF,QBI)+QB(1);
QmF(:)=QmF(:)-Qm(1);
Q0F(:)=Q0F(:)-Q0(1);
QRF(:)=QRF(:)-QR(1);
QBF(:)=QBF(:)-QB(1);
QmF=QmF*1000/60;
Q0F=Q0F*1000/60;
QRF=QRF*1000/60;
QBF=QBF*1000/60;
QmF(:)=QmF(:)-QmF(length(QmF));
Q0F(:)=Q0F(:)-Q0F(length(Q0F));
QRF(:)=QRF(:)-QRF(length(QRF));
QBF(:)=QBF(:)-QBF(length(QBF));
QmFu=QmF+uq;
130
QmFd=QmF-uq;
Q0Fu=Q0F+uq;
Q0Fd=Q0F-uq;
QRFu=QRF+uq;
QRFd=QRF-uq;
QBFu=QBF+uq;
QBFd=QBF-uq;
QmFig=figure;
plot(tm,QmF,'black')
%title('Flowrate');
xlabel('Time [s]');
ylabel('FlowRate [mL/s]');
saveas(QmFig,'C:\Users\Ross\Documents\Research Related\Thesis\Inputs\...
Pictures\Qm.png','png');
Q0Fig=figure;
plot(t0,Q0F,'black')
%title('Flowrate');
xlabel('Time [s]');
ylabel('FlowRate [mL/s]');
saveas(Q0Fig,'C:\Users\Ross\Documents\Research Related\Thesis\Inputs\...
Pictures\Q0.png','png');
QRFig=figure;
plot(tR,QRF,'black')
%title('Flowrate');
xlabel('Time [s]');
ylabel('FlowRate [mL/s]');
saveas(QRFig,'C:\Users\Ross\Documents\Research Related\Thesis\Inputs\...
Pictures\QR.png','png');
QBFig=figure;
plot(tB,QBF,'black')
%title('Flowrate');
xlabel('Time [s]');
ylabel('FlowRate [mL/s]');
saveas(QBFig,'C:\Users\Ross\Documents\Research Related\Thesis\Inputs\...
Pictures\QB.png','png');
%}
%% Flow Per Cycle
Nm=length(Qm);
N0=length(Q0);
NR=length(QR);
NB=length(QB);
M=SPS*period;
ncycm=Nm/M;
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ncyc0=N0/M;
ncycR=NR/M;
ncycB=NB/M;
Flowm=zeros(M,1);
Flow0=zeros(M,1);
FlowR=zeros(M,1);
FlowB=zeros(M,1);
for k=0:ncycm-1
Flowm(k+1,1)=trapz(tm(k*M+[1:M]'),QmF(k*M+[1:M]'));
Flowmu(k+1,1)=trapz(tm(k*M+[1:M]'),QmFu(k*M+[1:M]'));
Flowmd(k+1,1)=trapz(tm(k*M+[1:M]'),QmFd(k*M+[1:M]'));
end
for k=0:ncyc0-1
Flow0(k+1,1)=trapz(t0(k*M+[1:M]'),Q0F(k*M+[1:M]'));
Flow0u(k+1,1)=trapz(t0(k*M+[1:M]'),Q0Fu(k*M+[1:M]'));
Flow0d(k+1,1)=trapz(t0(k*M+[1:M]'),Q0Fd(k*M+[1:M]'));
end
for k=0:ncycR-1
FlowR(k+1,1)=trapz(tR(k*M+[1:M]'),QRF(k*M+[1:M]'));
FlowRu(k+1,1)=trapz(tR(k*M+[1:M]'),QRFu(k*M+[1:M]'));
FlowRd(k+1,1)=trapz(tR(k*M+[1:M]'),QRFd(k*M+[1:M]'));
end
for k=0:ncycB-1
FlowB(k+1,1)=trapz(tB(k*M+[1:M]'),QBF(k*M+[1:M]'));
FlowBu(k+1,1)=trapz(tB(k*M+[1:M]'),QBFu(k*M+[1:M]'));
FlowBd(k+1,1)=trapz(tB(k*M+[1:M]'),QBFd(k*M+[1:M]'));
end
um=(Flowmu-Flowmd)/2;
u0=(Flow0u-Flow0d)/2;
uR=(FlowRu-FlowRd)/2;
uB=(FlowBu-FlowBd)/2;
CycleMeanm=mean(Flowm(5:100));
CycleMean0=mean(Flow0(5:100));
CycleMeanR=mean(FlowR(5:100));
CycleMeanB=mean(FlowB(5:100));
Flowm(:)=Flowm(:)-Flowm(1);
Flow0(:)=Flow0(:)-Flow0(1);
FlowR(:)=FlowR(:)-FlowR(1);
FlowB(:)=FlowB(:)-FlowB(1);
FlowmFig=figure;
plot(tmAvg,Flowm,'black');
%title('Flow per Cycle');
xlabel('Time [s]');
ylabel('FlowRate [mL]');
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saveas(FlowmFig,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\Flowm.png','png');
Flow0Fig=figure;
plot(t0Avg,Flow0,'black');
%title('Flow per Cycle');
xlabel('Time [s]');
ylabel('FlowRate [mL]');
saveas(Flow0Fig,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\Flow0.png','png');
FlowRFig=figure;
plot(tRAvg,FlowR,'black');
%title('Flow per Cycle');
xlabel('Time [s]');
ylabel('FlowRate [mL]');
saveas(FlowRFig,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\FlowR.png','png');
FlowBFig=figure;
plot(tBAvg,FlowB,'black');
%title('Flow per Cycle');
xlabel('Time [s]');
ylabel('FlowRate [mL]');
saveas(FlowBFig,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\FlowB.png','png');
%% Recovery Time
k=0;
count=1;
while k==0
if P1mRN(count)>0.96
tmR96=tmR(count);
k=1;
end
count=count+1;
end
k=0;
count=1;
while k==0
if P1mRNu(count)>0.96
tmuR96=tmR(count);
k=1;
end
count=count+1;
end
k=0;
count=1;
while k==0
if P1mRNd(count)>0.96
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tmdR96=tmR(count);
k=1;
end
count=count+1;
end
utm=abs((tmuR96-tmdR96)/2);
k=0;
count=17;
while k==0
if P10RN(count)>0.96
t0R96=t0R(count);
k=1;
end
count=count+1;
end
k=0;
count=17;
while k==0
if P10RNu(count)>0.96
t0uR96=t0R(count);
k=1;
end
count=count+1;
end
k=0;
count=17;
while k==0
if P10RNd(count)>0.96
t0dR96=t0R(count);
k=1;
end
count=count+1;
end
ut0=abs((t0uR96-t0dR96)/2);
k=0;
count=1;
while k==0
if P1BRN(count)>0.96
tBR96=tBR(count);
k=1;
end
count=count+1;
end
k=0;
count=1;
while k==0
if P1BRNu(count)>0.96
tBuR96=tBR(count);
k=1;
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end
count=count+1;
end
k=0;
count=1;
while k==0
if P1BRNd(count)>0.96
tBdR96=tBR(count);
k=1;
end
count=count+1;
end
utB=abs((tBuR96-tBdR96)/2);
k=0;
count=45;
while k==0
if P1RRN(count)<1.04
tRR96=tRR(count);
k=1;
end
count=count+1;
end
k=0;
count=45;
while k==0
if P1RRNu(count)<1.04
tRuR96=tRR(count);
k=1;
end
count=count+1;
end
k=0;
count=45;
while k==0
if P1RRNd(count)<1.04
tRdR96=tRR(count);
k=1;
end
count=count+1;
end
utR=abs((tRuR96-tRdR96)/2);
%% Reflux
RefluxPerfect=figure;
subplot(2,1,1)
plot(tmR,P1mR,'black')
%title('Pressure During Recover');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
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axis([0,95,0,150]);
subplot(2,1,2)
plot(tmR,QmF(Off+1:length(QmF)),'black')
%title('Flowrate');
xlabel('Time [s]');
ylabel('FlowRate [mL/s]');
axis([0,95,-10,10]);
saveas(RefluxPerfect,'C:\Users\Ross\Documents\Research Related\Thesis...
\Inputs\Pictures\RefluxPerfect.png','png');
RefluxBio=figure;
subplot(2,1,1)
plot(tBR,P1BR,'black')
%title('Pressure During Recover');
xlabel('Time [s]');
ylabel('Pressure [mmHg]');
axis([0,95,0,150]);
subplot(2,1,2)
plot(tBR,QBF(Off+1:length(QBF)),'black')
%title('Flowrate');
xlabel('Time [s]');
ylabel('FlowRate [mL/s]');
axis([0,95,-10,10]);
saveas(RefluxBio,'C:\Users\Ross\Documents\Research Related\Thesis\...
Inputs\Pictures\RefluxBio.png','png');
%}
%%
set(0,'DefaultAxesFontSize','default');
C.4.2 parse.m
function[t,P1,P2,Q,tAvg,P1Avg,P2Avg]=parse(dat,period,SPS)
t(:,1)=dat(:,1)-dat(1,1);
P1(:,1)=dat(:,4);
P2(:,1)=dat(:,5);
Q(:,1)=dat(:,2);
%% Pressure Averaged Over the Cycle
N=length(dat);
M=SPS*period;
ncyc=N/M;
tAvg=zeros(floor(ncyc),1);
P2Avg=zeros(floor(ncyc),1);
P1Avg=zeros(floor(ncyc),1);
for i=1:1:ncyc
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tAvg(i)=t((i-1)*M+1);
P2Avg(i)=mean(P2((i-1)*M+1:i*M));
P1Avg(i)=mean(P1((i-1)*M+1:i*M));
end
C.5 Opening Pressure Calculation
C.5.1 OpeningPressure.m
%% Opening Pressure of Valve
clear
clc
close all
%% Load Data
tol=.5;
dat=load('0603OP3.txt');
up=1.76;
uq=0.026;
set(0,'defaulttextfontsize',18);
%% Parse Data
[t,P1,P2,Q,R,Ri,Rmean,Rstd,ur]=Rfun(dat,tol,up,uq);
%% filtfilt
P1I=P1-P1(1);
P2I=P2-P2(1);
QI=Q-Q(1);
fsF=80; % Sample Freuency
fnF=fsF/2; % Nyquist Frequency
fcF=1.5; % Desired Cutoff frequency (example)
[bF,aF]=butter(2,fcF/fnF); % IIR filtfilt coefficients, b=num, a=...
denom
fcFq=1.5; % Desired Cutoff frequency (example)
[bFq,aFq]=butter(2,fcFq/fnF); % IIR filtfilt coefficients, b=num, a=...
denom
QF=filtfilt(bFq,aFq,QI)+Q(1);
P1F=filtfilt(bF,aF,P1I)+P1(1);
P2F=filtfilt(bF,aF,P2I)+P2(1);
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% Gate 1
% QF=QF(:)-1.25;
% tol2=1.2;
% Gate 2
% QF=QF(:)+.36;
% tol2=1;
% Bio 3
QF=QF(:)-0.25;
tol2=.175;
QFu=QF+0.026;
QFd=QF-0.026;
figure
plot(t,QF)
for i=1:length(t)
Pd(i)=P1(i)-P2(i);
end
figure
plot(t,Pd)
figure
plot(t,P1,t,P2)
%% Find Opening Pressures
c=0;
count=1;
iold=1;
for i=1:length(t)
if QF(i)>tol2 && QF(iold)<tol2
POC(count,1)=P1F(i)-P2F(i);
tPOC(count,1)=t(i);
I(count,1)=abs(QF(i));
I(count,2)=abs(QF(iold));
I(count,3)=i;
count=count+1;
end
iold=i;
end
c=0;
count=1;
iold=1;
for i=1:length(t)
if QFu(i)>tol2 && QFu(iold)<tol2
POCqu(count,1)=P1F(i)-P2F(i);
tPOCqu(count,1)=t(i);
Iqu(count,1)=abs(QFu(i));
Iqu(count,2)=abs(QFu(iold));
Iqu(count,3)=i;
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count=count+1;
end
iold=i;
end
c=0;
count=1;
iold=1;
for i=1:length(t)
if QFd(i)>tol2 && QFd(iold)<tol2
POCqd(count,1)=P1F(i)-P2F(i);
tPOCqd(count,1)=t(i);
Iqd(count,1)=abs(QFd(i));
Iqd(count,2)=abs(QFd(iold));
Iqd(count,3)=i;
count=count+1;
end
iold=i;
end
POCpu=POC+up;
POCpd=POC-up;
l(1)=length(POCpu);
l(2)=length(POCpd);
l(3)=length(POCqu);
l(4)=length(POCqd);
k=min(l);
for i=1:k
POCu(i)=sqrt(((POCpu(i)-POCpd(i))/2)ˆ2+((POCqu(i)-POCqd(i))/2)...
ˆ2);
end
figure
plot(t,QF,tPOC,POC,'o')
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